| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH4 MYH6 MYH7 DYNC2H1 MYO10 WRN TOR4A SRCAP MORC2 ATAD2 ABCA8 DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 MORC3 POLQ KIF13A DNAH8 DYNC1H1 TOP2B HELLS | 1.18e-13 | 614 | 139 | 26 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB9B MYH3 MYH4 MYH7 DYNC2H1 WRN GBP2 TOR4A RGS9 SRCAP MORC2 NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 GNA15 MORC3 POLQ KIF13A DNAH8 RAB27A DYNC1H1 | 5.78e-13 | 775 | 139 | 28 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUDT18 RAB9B MYH3 MYH4 MYH7 DYNC2H1 WRN GBP2 TOR4A RGS9 SRCAP MORC2 NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 GNA15 MORC3 POLQ KIF13A DNAH8 RAB27A DYNC1H1 | 6.27e-13 | 839 | 139 | 29 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUDT18 RAB9B MYH3 MYH4 MYH7 DYNC2H1 WRN GBP2 TOR4A RGS9 SRCAP MORC2 NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 GNA15 MORC3 POLQ KIF13A DNAH8 RAB27A DYNC1H1 | 6.46e-13 | 840 | 139 | 29 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUDT18 RAB9B MYH3 MYH4 MYH7 DYNC2H1 WRN GBP2 TOR4A RGS9 SRCAP MORC2 NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 GNA15 MORC3 POLQ KIF13A DNAH8 RAB27A DYNC1H1 | 6.46e-13 | 840 | 139 | 29 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYH4 MYH7 DYNC2H1 WRN TOR4A SRCAP MORC2 ATAD2 ABCA8 DHX9 ABCB4 LONP1 ABCB9 ACIN1 MACF1 MORC3 POLQ KIF13A DNAH8 DYNC1H1 | 3.84e-12 | 441 | 139 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.92e-09 | 118 | 139 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN TPR MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 ANK3 CLIP2 MYO10 TRPC5 BAG2 MYRIP GBP2 EPB41L3 SPAG5 BRCA2 MID1 CEP135 MACF1 MICAL3 PLEC KIF13A RAB27A | 1.46e-07 | 1099 | 139 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.35e-07 | 38 | 139 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 MYO10 TRPC5 MYRIP GBP2 EPB41L3 MACF1 MICAL3 PLEC | 6.57e-06 | 479 | 139 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 1.94e-04 | 227 | 139 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.12e-04 | 230 | 139 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.49e-04 | 18 | 139 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.65e-04 | 127 | 139 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | Y-form DNA binding | 2.86e-04 | 4 | 139 | 2 | GO:0000403 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.52e-04 | 28 | 139 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.44e-03 | 70 | 139 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.69e-03 | 34 | 139 | 3 | GO:0030507 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.30e-08 | 15 | 136 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 9.26e-08 | 18 | 136 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.05e-06 | 153 | 136 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | GPHN TPR RAPSN DYNC2H1 PARP3 WRN GBP2 SRP68 CNTLN WNK1 SPAG5 DHX9 IPO9 BRCA2 MID1 MACF1 MORC3 EIF2AK3 GOLGB1 KPNA1 VCPIP1 | 9.42e-06 | 1091 | 136 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.15e-05 | 127 | 136 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR SLK ANK3 CLIP2 PPP1R12A PARP3 CNTLN SPAG5 PPP2R1A KASH5 BRCA2 MID1 CEP135 CFAP206 DNAH8 DYNC1H1 | 2.19e-05 | 720 | 136 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | DNA recombination | RAD18 RNF168 PARP3 WRN MORC2 TRRAP KASH5 BRCA2 POLQ TOP2B KPNA1 | 3.35e-05 | 368 | 136 | 11 | GO:0006310 |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH2 ANK3 DYNC2H1 TRPC5 EPB41L3 WNK1 CIT COG6 SPACA1 PLEC HPS5 EIF2AK3 RAB27A GOLGB1 VCPIP1 | 3.82e-05 | 672 | 136 | 15 | GO:0010256 |
| GeneOntologyBiologicalProcess | sarcomere organization | 4.35e-05 | 59 | 136 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR SLK ANK3 CLIP2 DYNC2H1 PPP1R12A PARP3 CNTLN SPAG5 PPP2R1A KASH5 BRCA2 MID1 CEP135 CFAP206 MACF1 KIF13A DNAH8 DYNC1H1 | 6.69e-05 | 1058 | 136 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | TPR MYH3 MYH6 MYH7 WNK1 SPAG5 KASH5 SURF6 CEP135 AKAP13 PLEC DYNC1H1 | 7.44e-05 | 475 | 136 | 12 | GO:0140694 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 7.99e-05 | 156 | 136 | 7 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 7.99e-05 | 156 | 136 | 7 | GO:0010927 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 DSG2 MYRIP EPB41L3 CIT KASH5 SCN8A AKAP13 PRKCI MICAL3 CGNL1 PLEC | 1.07e-04 | 912 | 136 | 17 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 1.78e-04 | 17 | 136 | 3 | GO:0046831 | |
| GeneOntologyBiologicalProcess | chromosome organization | TPR PARP3 WRN MORC2 CIT SPAG5 DHX9 PPP2R1A WDHD1 KASH5 BRCA2 ACIN1 POLQ TOP2B | 1.79e-04 | 686 | 136 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | cell cycle process | TPR RAD18 ANK3 PPP1R12A PARP3 TCIM WRN CNTLN USP37 MORC2 WNK1 TRRAP CIT SPAG5 PPP2R1A KASH5 BRCA2 CEP135 PLEC KIF13A DYNC1H1 TOP2B | 1.84e-04 | 1441 | 136 | 22 | GO:0022402 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT3 MYH3 MYH6 MYH7 SLK CALD1 CLIP2 CIT KASH5 KRT71 MID1 AKAP13 PRKCI MICAL3 CGNL1 PLEC DYNC1H1 | 1.90e-04 | 957 | 136 | 17 | GO:0097435 |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 2.00e-04 | 44 | 136 | 4 | GO:0006346 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 2.63e-04 | 86 | 136 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | regulation of spindle organization | 2.81e-04 | 48 | 136 | 4 | GO:0090224 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 2.94e-04 | 20 | 136 | 3 | GO:0032239 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 3.05e-04 | 324 | 136 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 3.08e-04 | 89 | 136 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | DNA repair | RAD18 RNF168 PARP3 WRN MORC2 TRRAP DHX9 WDHD1 KASH5 BRCA2 POLQ TOP2B VCPIP1 | 3.62e-04 | 648 | 136 | 13 | GO:0006281 |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 4.75e-04 | 55 | 136 | 4 | GO:0140718 | |
| GeneOntologyBiologicalProcess | organelle assembly | TPR MYH3 MYH6 MYH7 DYNC2H1 WNK1 SPAG5 ODF2L KASH5 SPACA1 SURF6 CEP135 CFAP206 AKAP13 PLEC HPS5 DNAH8 DYNC1H1 | 4.97e-04 | 1138 | 136 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 5.13e-04 | 24 | 136 | 3 | GO:0031445 | |
| GeneOntologyCellularComponent | muscle myosin complex | 5.35e-08 | 16 | 141 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 1.39e-07 | 59 | 141 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT3 MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 ANK3 CLIP2 DYNC2H1 PPP1R12A BAG2 JPH2 SPAG5 KRT71 SIMC1 MID1 SCN8A CFAP206 MACF1 AKAP13 PLEC KIF13A DNAH8 DYNC1H1 | 3.10e-07 | 1179 | 141 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 ANK3 PPP1R12A JPH2 SIMC1 SCN8A PLEC | 3.46e-07 | 273 | 141 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT3 MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 ANK3 CLIP2 DYNC2H1 PPP1R12A BAG2 JPH2 SPAG5 KRT71 SIMC1 MID1 SCN8A CFAP206 MACF1 AKAP13 PLEC KIF13A DNAH8 DYNC1H1 | 3.52e-07 | 1187 | 141 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | myosin filament | 6.20e-07 | 25 | 141 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 ANK3 PPP1R12A JPH2 SIMC1 SCN8A PLEC | 6.57e-07 | 290 | 141 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | MYH2 MYH3 MYH4 MYH6 MYH7 ANK3 PPP1R12A JPH2 SIMC1 SCN8A PLEC | 1.03e-06 | 249 | 141 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | myosin II complex | 1.13e-06 | 28 | 141 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 MYO10 PPP1R12A MYRIP GBP2 CIT DHX9 MACF1 AKAP13 CGNL1 | 8.37e-06 | 576 | 141 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | Z disc | 7.52e-05 | 151 | 141 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.12e-04 | 161 | 141 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | I band | 1.36e-04 | 166 | 141 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | centrosome | RAD18 RAPSN SPOUT1 PPP1R12A PARP3 WRN CNTLN SPAG5 DHX9 ODF2L BRCA2 MID1 CEP135 KIF13A DYNC1H1 | 2.24e-04 | 770 | 141 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | dendritic microtubule | 2.69e-04 | 4 | 141 | 2 | GO:1901588 | |
| GeneOntologyCellularComponent | microtubule organizing center | RAD18 RAPSN SPOUT1 PPP1R12A PARP3 WRN CNTLN SPAG5 DHX9 ODF2L BRCA2 MID1 CEP135 CFAP206 KIF13A DYNC1H1 | 4.81e-04 | 919 | 141 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | dynein complex | 4.83e-04 | 54 | 141 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | cytoplasmic dynein complex | 5.48e-04 | 24 | 141 | 3 | GO:0005868 | |
| GeneOntologyCellularComponent | chromosomal region | TPR SPOUT1 PPP1R12A WRN SPAG5 PPP2R1A WDHD1 KASH5 BRCA2 HELLS | 5.85e-04 | 421 | 141 | 10 | GO:0098687 |
| GeneOntologyCellularComponent | cell cortex | 9.50e-04 | 371 | 141 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT3 CALD1 CLIP2 DYNC2H1 BAG2 SPAG5 KRT71 MID1 CFAP206 MACF1 AKAP13 PLEC KIF13A DNAH8 DYNC1H1 | 1.11e-03 | 899 | 141 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | junctional membrane complex | 1.58e-03 | 9 | 141 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.71e-03 | 254 | 141 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | replication fork | 1.83e-03 | 77 | 141 | 4 | GO:0005657 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.96e-03 | 10 | 141 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.73e-03 | 276 | 141 | 7 | GO:0000775 | |
| Domain | P-loop_NTPase | RAB9B MYH2 MYH3 MYH4 MYH6 MYH7 DYNC2H1 MYO10 WRN GBP2 TOR4A SRCAP NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 GNA15 POLQ KIF13A DNAH8 RAB27A DYNC1H1 HELLS | 1.29e-10 | 848 | 139 | 27 | IPR027417 |
| Domain | Myosin_tail_1 | 2.63e-09 | 18 | 139 | 6 | PF01576 | |
| Domain | Myosin_tail | 2.63e-09 | 18 | 139 | 6 | IPR002928 | |
| Domain | Myosin_N | 6.01e-08 | 15 | 139 | 5 | PF02736 | |
| Domain | Myosin_N | 6.01e-08 | 15 | 139 | 5 | IPR004009 | |
| Domain | Myosin-like_IQ_dom | 2.27e-07 | 19 | 139 | 5 | IPR027401 | |
| Domain | - | 2.27e-07 | 19 | 139 | 5 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 3.46e-07 | 38 | 139 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.46e-07 | 38 | 139 | 6 | PS51456 | |
| Domain | Myosin_head | 3.46e-07 | 38 | 139 | 6 | PF00063 | |
| Domain | MYSc | 3.46e-07 | 38 | 139 | 6 | SM00242 | |
| Domain | - | RAB9B DYNC2H1 WRN GBP2 TOR4A SRCAP NKIRAS1 ATAD2 ABCA8 ARL4D DHX9 ABCB4 LONP1 ABCB9 GNA15 POLQ DNAH8 RAB27A DYNC1H1 HELLS | 6.70e-07 | 746 | 139 | 20 | 3.40.50.300 |
| Domain | AAA | 1.31e-06 | 144 | 139 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 1.31e-06 | 144 | 139 | 9 | IPR003593 | |
| Domain | IQ | 2.39e-06 | 81 | 139 | 7 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.85e-06 | 90 | 139 | 7 | IPR000048 | |
| Domain | IQ | 6.04e-06 | 93 | 139 | 7 | PS50096 | |
| Domain | IQ | 1.47e-05 | 71 | 139 | 6 | PF00612 | |
| Domain | DHC_N1 | 2.20e-05 | 8 | 139 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.20e-05 | 8 | 139 | 3 | IPR013594 | |
| Domain | PP2A_A_meta | 5.50e-05 | 2 | 139 | 2 | IPR031090 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.38e-04 | 14 | 139 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.38e-04 | 14 | 139 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.38e-04 | 14 | 139 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.38e-04 | 14 | 139 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.38e-04 | 14 | 139 | 3 | IPR011704 | |
| Domain | MT | 1.38e-04 | 14 | 139 | 3 | PF12777 | |
| Domain | AAA_8 | 1.38e-04 | 14 | 139 | 3 | PF12780 | |
| Domain | AAA_5 | 1.38e-04 | 14 | 139 | 3 | PF07728 | |
| Domain | Ser-tRNA-synth_1_N | 1.64e-04 | 3 | 139 | 2 | IPR015866 | |
| Domain | - | 1.64e-04 | 3 | 139 | 2 | 1.10.287.40 | |
| Domain | DHC_fam | 1.72e-04 | 15 | 139 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.72e-04 | 15 | 139 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.72e-04 | 15 | 139 | 3 | IPR004273 | |
| Domain | Junctophilin | 3.27e-04 | 4 | 139 | 2 | IPR017191 | |
| Domain | HATPase_c | 3.58e-04 | 19 | 139 | 3 | PF02518 | |
| Domain | - | 4.19e-04 | 20 | 139 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 4.86e-04 | 21 | 139 | 3 | IPR003594 | |
| Domain | - | 4.86e-04 | 21 | 139 | 3 | 1.10.720.30 | |
| Domain | SAP | 5.60e-04 | 22 | 139 | 3 | PF02037 | |
| Domain | SAP | 6.41e-04 | 23 | 139 | 3 | SM00513 | |
| Domain | tRNA-bd_arm | 7.28e-04 | 24 | 139 | 3 | IPR010978 | |
| Domain | - | 8.09e-04 | 6 | 139 | 2 | 3.90.1290.10 | |
| Domain | SAP | 8.23e-04 | 25 | 139 | 3 | PS50800 | |
| Domain | SAP_dom | 8.23e-04 | 25 | 139 | 3 | IPR003034 | |
| Domain | zf-CW | 1.13e-03 | 7 | 139 | 2 | PF07496 | |
| Domain | ZF_CW | 1.13e-03 | 7 | 139 | 2 | PS51050 | |
| Domain | Plectin | 1.13e-03 | 7 | 139 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.13e-03 | 7 | 139 | 2 | IPR001101 | |
| Domain | Znf_CW | 1.13e-03 | 7 | 139 | 2 | IPR011124 | |
| Domain | PLEC | 1.13e-03 | 7 | 139 | 2 | SM00250 | |
| Domain | Helicase_C | 1.23e-03 | 107 | 139 | 5 | PF00271 | |
| Domain | HELICc | 1.23e-03 | 107 | 139 | 5 | SM00490 | |
| Domain | Helicase_C | 1.28e-03 | 108 | 139 | 5 | IPR001650 | |
| Domain | ZF_DAG_PE_1 | 1.32e-03 | 64 | 139 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.32e-03 | 64 | 139 | 4 | PS50081 | |
| Domain | HELICASE_CTER | 1.34e-03 | 109 | 139 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.34e-03 | 109 | 139 | 5 | PS51192 | |
| Domain | DEXDc | 1.34e-03 | 109 | 139 | 5 | SM00487 | |
| Domain | - | 1.38e-03 | 222 | 139 | 7 | 1.25.10.10 | |
| Domain | Helicase_ATP-bd | 1.39e-03 | 110 | 139 | 5 | IPR014001 | |
| Domain | C1 | 1.40e-03 | 65 | 139 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.48e-03 | 66 | 139 | 4 | IPR002219 | |
| Domain | DUF1220 | 1.91e-03 | 9 | 139 | 2 | SM01148 | |
| Domain | EMI | 2.38e-03 | 10 | 139 | 2 | PF07546 | |
| Domain | DUF1220 | 2.89e-03 | 11 | 139 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.89e-03 | 11 | 139 | 2 | IPR010630 | |
| Domain | NBPF | 2.89e-03 | 11 | 139 | 2 | PS51316 | |
| Domain | GrpE_coiled_coil | 3.46e-03 | 12 | 139 | 2 | IPR013805 | |
| Domain | ARM-like | 4.13e-03 | 270 | 139 | 7 | IPR011989 | |
| Domain | MORN | 4.72e-03 | 14 | 139 | 2 | SM00698 | |
| Domain | MORN | 5.42e-03 | 15 | 139 | 2 | IPR003409 | |
| Domain | MORN | 5.42e-03 | 15 | 139 | 2 | PF02493 | |
| Domain | ABC_tran | 5.46e-03 | 48 | 139 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.46e-03 | 48 | 139 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.79e-03 | 49 | 139 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 6.12e-03 | 50 | 139 | 3 | IPR003439 | |
| Domain | EMI_domain | 6.16e-03 | 16 | 139 | 2 | IPR011489 | |
| Domain | EMI | 6.95e-03 | 17 | 139 | 2 | PS51041 | |
| Domain | HEAT_type_2 | 6.95e-03 | 17 | 139 | 2 | IPR021133 | |
| Domain | Kinase-like_dom | 7.38e-03 | 542 | 139 | 10 | IPR011009 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.10e-06 | 132 | 113 | 9 | M11355 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 5.78e-05 | 10 | 113 | 3 | MM14509 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 1.35e-04 | 13 | 113 | 3 | M1015 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN TPR SLK CALD1 NOP56 DSG2 PPP1R12A SRP68 SRCAP EPB41L3 WNK1 SPAG5 SURF6 EIF4B KMT2A ACIN1 MACF1 CGNL1 SF3B2 TOP2B GOLGB1 VCPIP1 HDLBP HELLS | 6.83e-13 | 934 | 142 | 24 | 33916271 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH2 MYH4 MYH7 NOP56 PPP1R12A PARP3 BAG2 SPTLC1 SRPK2 CCDC6 EPB41L3 TRRAP DHX9 PPP2R1A IPO9 SARS2 LUC7L2 CEP135 ACIN1 AKAP13 POLQ SF3B2 DYNC1H1 JPH3 KPNA1 HDLBP HELLS | 2.28e-12 | 1284 | 142 | 27 | 17353931 |
| Pubmed | SLK HIRIP3 NOP56 PPP1R12A MED8 SRP68 SRCAP MORC2 EPB41L3 ATAD2 WNK1 SPAG5 ODF2L IPO9 CEP135 KMT2A MICAL3 MORC3 VCPIP1 HELLS | 2.36e-12 | 645 | 142 | 20 | 25281560 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CYC1 TPR SLK NOP56 BAG2 SRP68 SRPK2 RDH13 WNK1 SPAG5 DHX9 PPP2R1A LONP1 LUC7L2 PRIM2 EIF4B MACF1 AKAP13 PLEC QARS1 SF3B2 DYNC1H1 TOP2B GOLGB1 KPNA1 VCPIP1 HDLBP HELLS | 3.55e-12 | 1415 | 142 | 28 | 28515276 |
| Pubmed | NUDT18 CYC1 GPHN CACNA1A MYH6 SLK CALD1 ANK3 CLIP2 VPS45 PPFIA4 PPP1R12A SRP68 SRPK2 EPB41L3 CIT DHX9 PPP2R1A LONP1 EIF4B SCAPER KMT2A MACF1 MICAL3 CGNL1 PLEC DYNC1H1 HDLBP | 4.63e-12 | 1431 | 142 | 28 | 37142655 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CYC1 TPR SLK CALD1 NOP56 PARP3 SRPK2 SRCAP WNK1 CIT PPP2R1A IPO9 LUC7L2 EIF4B SCAPER MACF1 PLEC QARS1 SF3B2 DYNC1H1 GOLGB1 KPNA1 | 5.58e-12 | 847 | 142 | 22 | 35235311 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR MYH7 SLK CALD1 NOP56 ANK3 PPP1R12A BAG2 SRP68 SRPK2 DHX9 PPP2R1A IPO9 KRT71 LUC7L2 EIF4B MID1 MACF1 MICAL3 PLEC QARS1 SF3B2 DYNC1H1 KPNA1 HDLBP | 8.00e-12 | 1149 | 142 | 25 | 35446349 |
| Pubmed | TPR CALD1 NOP56 ANK3 DSG2 BAG2 SRP68 EPB41L3 DHX9 PPP2R1A EIF4B MACF1 MICAL3 QARS1 EIF2AK3 SF3B2 DYNC1H1 GOLGB1 VCPIP1 HDLBP | 1.26e-11 | 708 | 142 | 20 | 39231216 | |
| Pubmed | GPHN TPR SLK CALD1 NOP56 ANK3 DSG2 PPP1R12A MED8 SRP68 SRCAP TRRAP PPP2R1A KMT2A ACIN1 DYNC1H1 VCPIP1 HDLBP | 1.29e-11 | 549 | 142 | 18 | 38280479 | |
| Pubmed | 2.21e-11 | 7 | 142 | 5 | 16819597 | ||
| Pubmed | TPR SLK CALD1 DSG2 CCDC6 COG6 SURF6 MMRN2 ACIN1 MACF1 MICAL3 PLEC SF3B2 DYNC1H1 GOLGB1 | 2.62e-11 | 360 | 142 | 15 | 33111431 | |
| Pubmed | KRT3 MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 NOP56 PPFIA4 PPP1R12A MED8 MYRIP SRCAP EPB41L3 ABCB4 ABCB9 KRT71 EIF4B KMT2A ACIN1 MACF1 PLEC POLQ DNAH8 TOP2B GOLGB1 CCDC158 | 3.20e-11 | 1442 | 142 | 27 | 35575683 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR RAD18 SRP68 EPB41L3 DHX9 PPP2R1A PPP2R1B IPO9 LUC7L2 ACIN1 MACF1 PLEC SF3B2 DYNC1H1 GOLGB1 KPNA1 HDLBP HELLS | 3.35e-11 | 582 | 142 | 18 | 20467437 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR NOP56 SPOUT1 BAG2 WDR46 SRP68 TOR4A SRCAP EPB41L3 ATAD2 TRRAP DHX9 PPP2R1A LONP1 IPO9 PRIM2 ACIN1 MACF1 AKAP13 PLEC QARS1 SF3B2 DYNC1H1 TOP2B KPNA1 HDLBP | 4.46e-11 | 1353 | 142 | 26 | 29467282 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPHN MYH2 MYH4 SLK DYNC2H1 MYO10 WRN SRP68 CCDC6 USP37 TRRAP PRKD3 PPP2R1B LONP1 IPO9 SARS2 PRIM2 EIF4B PRKCI PLEC KPNA1 VCPIP1 | 1.48e-10 | 1005 | 142 | 22 | 19615732 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR CALD1 NOP56 DSG2 BAG2 WDR46 SRCAP TRRAP CIT DHX9 PPP2R1A LONP1 ACIN1 MACF1 PLEC QARS1 SF3B2 DYNC1H1 TOP2B GOLGB1 HDLBP HELLS | 2.10e-10 | 1024 | 142 | 22 | 24711643 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN SLK HIRIP3 CALD1 PPP1R12A BAG2 GBP2 SRP68 CCDC6 WNK1 DHX9 PPP2R1A PPP2R1B IPO9 WDHD1 LUC7L2 PRIM2 EIF4B MACF1 PLEC QARS1 KIF13A DYNC1H1 KPNA1 VCPIP1 HDLBP | 2.14e-10 | 1455 | 142 | 26 | 22863883 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CYC1 NOP56 ANK3 PPP1R12A BAG2 MORC2 EPB41L3 TRRAP PPP2R1A LUC7L2 SURF6 EIF4B KMT2A MICAL3 QARS1 HELLS | 2.48e-10 | 497 | 142 | 16 | 36774506 |
| Pubmed | CYC1 MYH7 HIRIP3 NOP56 DYNC2H1 SPTLC1 GBP2 SRP68 MORC2 TRRAP BRCA2 SURF6 EIF4B KIF13A SF3B2 DYNC1H1 GOLGB1 KPNA1 HDLBP | 2.93e-10 | 754 | 142 | 19 | 35906200 | |
| Pubmed | RNF168 ANK3 LAMA4 RNF14 PPP2R1A LUC7L2 CEP135 ABTB1 MACF1 PLEC QARS1 KIF13A DYNC1H1 GOLGB1 KPNA1 VCPIP1 HDLBP | 3.70e-10 | 591 | 142 | 17 | 15231748 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR RAD18 HIRIP3 CCDC6 MORC2 ATAD2 TRRAP DHX9 ABCB9 WDHD1 EIF4B KMT2A ACIN1 MICAL3 PLEC SF3B2 TOP2B VCPIP1 HDLBP | 4.53e-10 | 774 | 142 | 19 | 15302935 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | TPR SLK DSG2 SRP68 SPAG5 EIF4B PLEC SF3B2 DYNC1H1 GOLGB1 VCPIP1 HDLBP | 7.30e-10 | 256 | 142 | 12 | 33397691 |
| Pubmed | TPR CALD1 NOP56 ANK3 DSG2 BAG2 SRP68 TOR4A SPAG5 DHX9 LONP1 BRCA2 ACIN1 MACF1 TOP2B KPNA1 HDLBP | 1.07e-09 | 634 | 142 | 17 | 34591612 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK CALD1 NOP56 SPOUT1 PPP1R12A WDR46 SRP68 MORC2 EPB41L3 PPP2R1A EIF4B MACF1 AKAP13 PLEC QARS1 TOP2B HDLBP HELLS | 1.10e-09 | 724 | 142 | 18 | 36232890 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR MYH2 MYH3 MYH4 MYH6 MYH7 PPP1R12A BAG2 TOR4A PPP2R1A PPP2R1B IPO9 COG6 PLEC QARS1 SF3B2 DYNC1H1 | 1.45e-09 | 647 | 142 | 17 | 26618866 |
| Pubmed | 1.50e-09 | 118 | 142 | 9 | 30979931 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CYC1 GPHN TPR RAD18 CALD1 NOP56 DSG2 PPP1R12A SPAG5 DHX9 PPP2R1A PPP2R1B ODF2L EIF4B CEP135 PRKCI MICAL3 MORC3 SF3B2 DYNC1H1 TOP2B KPNA1 | 1.95e-09 | 1155 | 142 | 22 | 20360068 |
| Pubmed | TPR NOP56 SPOUT1 CLIP2 DSG2 PPP1R12A BAG2 SRP68 SRPK2 ATAD2 TRRAP DHX9 LUC7L2 SURF6 KMT2A ACIN1 QARS1 SF3B2 TOP2B | 1.99e-09 | 847 | 142 | 19 | 35850772 | |
| Pubmed | CLIP2 DYNC2H1 PPFIA4 USP37 MORC2 EPB41L3 WNK1 ABCA8 IPO9 CEP135 SCAPER MACF1 MICAL3 CGNL1 MORC3 | 2.00e-09 | 493 | 142 | 15 | 15368895 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN DSG2 PPP1R12A CCDC6 PITPNC1 EPB41L3 WNK1 IPO9 EIF4B KMT2A MACF1 AKAP13 PRKCI CGNL1 PLEC MORC3 KIF13A GOLGB1 VCPIP1 | 2.60e-09 | 861 | 142 | 19 | 36931259 |
| Pubmed | NLRP11 TPR PPP1R12A DHX9 MACF1 CGNL1 PLEC KIF13A SF3B2 TOP2B GOLGB1 | 3.72e-09 | 234 | 142 | 11 | 36243803 | |
| Pubmed | 3.97e-09 | 6 | 142 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.97e-09 | 6 | 142 | 4 | 10588881 | |
| Pubmed | NOP56 DSG2 BAG2 SRP68 DHX9 PPP2R1A LONP1 IPO9 WDHD1 PRIM2 PLEC QARS1 SF3B2 DYNC1H1 TOP2B HELLS | 8.77e-09 | 638 | 142 | 16 | 33239621 | |
| Pubmed | 9.23e-09 | 7 | 142 | 4 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 9.23e-09 | 7 | 142 | 4 | 29758057 | |
| Pubmed | TPR WDR46 SRP68 EPB41L3 ATAD2 TRRAP PPP2R1A LONP1 SURF6 KMT2A ACIN1 MACF1 PLEC SF3B2 DYNC1H1 HDLBP | 1.21e-08 | 653 | 142 | 16 | 22586326 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CALD1 DSG2 VPS45 CNTLN SPAG5 LONP1 ODF2L BRCA2 LUC7L2 EIF4B SIMC1 CEP135 MICAL3 CGNL1 PLEC MORC3 DYNC1H1 VCPIP1 | 1.40e-08 | 853 | 142 | 18 | 28718761 |
| Pubmed | TPR ANK3 CLIP2 LAMA4 EPB41L3 WNK1 SIMC1 MACF1 AKAP13 BICRAL CGNL1 PLEC GOLGB1 HDLBP | 1.41e-08 | 486 | 142 | 14 | 20936779 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR SLK NOP56 DSG2 DYNC2H1 WDR46 SPTLC1 SRP68 EPB41L3 ATAD2 DHX9 PPP2R1A LONP1 IPO9 LUC7L2 ACIN1 PRKCI QARS1 SF3B2 DYNC1H1 TOP2B HDLBP HELLS | 1.79e-08 | 1425 | 142 | 23 | 30948266 |
| Pubmed | 1.84e-08 | 8 | 142 | 4 | 3864153 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RAD18 DYNC2H1 CNTLN CCDC6 SRCAP WNK1 PPP2R1A ODF2L BRCA2 MACF1 CGNL1 MORC3 GOLGB1 VCPIP1 HDLBP | 2.10e-08 | 588 | 142 | 15 | 38580884 |
| Pubmed | TPR CALD1 NOP56 DSG2 BAG2 SRP68 PPP2R1A LONP1 SURF6 ACIN1 PLEC HPS5 QARS1 DYNC1H1 TOP2B GOLGB1 HDLBP | 2.56e-08 | 786 | 142 | 17 | 29128334 | |
| Pubmed | NOP56 SRPK2 DHX9 PPP2R1A LONP1 IPO9 KMT2A MACF1 AKAP13 PLEC SF3B2 DYNC1H1 TOP2B HDLBP HELLS | 2.80e-08 | 601 | 142 | 15 | 33658012 | |
| Pubmed | TPR RAD18 RNF168 MED8 MORC2 TRRAP DHX9 PPP2R1A LONP1 WDHD1 PRIM2 KMT2A ACIN1 PLEC MBD2 MAGEC2 SF3B2 TOP2B HELLS | 3.56e-08 | 1014 | 142 | 19 | 32416067 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 6.66e-08 | 3 | 142 | 3 | 1694848 | |
| Pubmed | Interaction between protein phosphatase 2A and members of the importin beta superfamily. | 6.66e-08 | 3 | 142 | 3 | 12670497 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 6.66e-08 | 3 | 142 | 3 | 1939265 | |
| Pubmed | MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses. | 6.66e-08 | 3 | 142 | 3 | 30842214 | |
| Pubmed | CYC1 SLK NOP56 DSG2 PPP1R12A SPTLC1 SRP68 SRPK2 RDH13 WNK1 TRRAP DHX9 PPP2R1A SURF6 EIF4B MACF1 AKAP13 PRKCI QARS1 DYNC1H1 HELLS | 7.62e-08 | 1297 | 142 | 21 | 33545068 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 8.60e-08 | 11 | 142 | 4 | 16024798 | |
| Pubmed | GPHN CACNA1A TPR SLK NOP56 ANK3 CLIP2 PPP1R12A SRPK2 CCDC6 EPB41L3 CIT PPP2R1A MACF1 PRKCI DYNC1H1 GOLGB1 KPNA1 | 8.71e-08 | 963 | 142 | 18 | 28671696 | |
| Pubmed | MYH2 CALD1 NOP56 VPS45 BAG2 SPTLC1 RDH13 SPAG5 PPP2R1A PPP2R1B LONP1 IPO9 COG6 LUC7L2 SURF6 KMT2A MICAL3 QARS1 RAB27A DYNC1H1 TOP2B HELLS | 9.90e-08 | 1440 | 142 | 22 | 30833792 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR SRP68 SRCAP PPP2R1A WDHD1 ACIN1 PLEC MORC3 SF3B2 DYNC1H1 HDLBP | 1.33e-07 | 332 | 142 | 11 | 32786267 |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 1.61e-07 | 202 | 142 | 9 | 33601422 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.85e-07 | 13 | 142 | 4 | 8404542 | |
| Pubmed | NOP56 SPOUT1 CLIP2 DSG2 WRN SRP68 SRPK2 MORC2 PRKD3 IPO9 SARS2 LUC7L2 KMT2A ACIN1 PRKCI PLEC QARS1 MBD2 SF3B2 DYNC1H1 HDLBP | 1.92e-07 | 1371 | 142 | 21 | 36244648 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR KRT3 NOP56 BAG2 SRP68 DHX9 LUC7L2 KMT2A ACIN1 MBD2 SF3B2 TOP2B KPNA1 HELLS | 2.09e-07 | 605 | 142 | 14 | 28977666 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR KRT3 NOP56 SPOUT1 DSG2 PPP1R12A SRP68 SRPK2 CIT DHX9 PPP2R1A SURF6 EIF4B ACIN1 PLEC QARS1 SF3B2 DYNC1H1 KPNA1 HDLBP | 2.12e-07 | 1257 | 142 | 20 | 36526897 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | NOP56 ANK3 DYNC2H1 SRCAP SPAG5 DHX9 PPP2R1A GJA8 SCN8A KMT2A MACF1 AKAP13 PLEC QARS1 DYNC1H1 HDLBP | 2.19e-07 | 807 | 142 | 16 | 30575818 |
| Pubmed | 2.24e-07 | 210 | 142 | 9 | 16565220 | ||
| Pubmed | 2.58e-07 | 14 | 142 | 4 | 27184118 | ||
| Pubmed | 2.58e-07 | 14 | 142 | 4 | 24938781 | ||
| Pubmed | 2.85e-07 | 216 | 142 | 9 | 31519766 | ||
| Pubmed | CALD1 NOP56 SPOUT1 CLIP2 MYO10 SRP68 SRPK2 DHX9 LUC7L2 SURF6 EIF4B PRKCI QARS1 SF3B2 KPNA1 | 3.03e-07 | 723 | 142 | 15 | 34133714 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 3.51e-07 | 15 | 142 | 4 | 24852826 | |
| Pubmed | TPR SLK DSG2 VPS45 JPH2 SRP68 EPB41L3 PPP2R1A IPO9 EIF4B GOLGB1 HDLBP | 3.55e-07 | 449 | 142 | 12 | 31732153 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR RNF168 CALD1 NOP56 SPOUT1 DSG2 MYO10 PPP1R12A BAG2 WDR46 SRP68 DHX9 LUC7L2 EIF4B PLEC SF3B2 DYNC1H1 | 3.70e-07 | 949 | 142 | 17 | 36574265 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 3.86e-07 | 163 | 142 | 8 | 22113938 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CYC1 TPR RAD18 CALD1 NOP56 EPB41L3 DHX9 BRCA2 SURF6 EIF4B SIMC1 KMT2A ACIN1 SF3B2 TOP2B HDLBP HELLS | 3.98e-07 | 954 | 142 | 17 | 36373674 |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 4.67e-07 | 16 | 142 | 4 | 19922871 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GPHN TPR MYH7 PPP1R12A SRPK2 MORC2 TRRAP WDHD1 QARS1 MBD2 EIF2AK3 SF3B2 DYNC1H1 TOP2B KPNA1 HELLS | 4.86e-07 | 857 | 142 | 16 | 25609649 |
| Pubmed | RAD18 PPP1R12A BAG2 SPTLC1 SRP68 TRRAP DHX9 PPP2R1A PPP2R1B LONP1 IPO9 SARS2 LUC7L2 PRIM2 EIF4B SIMC1 QARS1 SF3B2 KPNA1 HDLBP | 5.47e-07 | 1335 | 142 | 20 | 29229926 | |
| Pubmed | 6.08e-07 | 17 | 142 | 4 | 16124007 | ||
| Pubmed | TPR NOP56 SRP68 SRCAP TRRAP DHX9 IPO9 LUC7L2 SF3B2 KPNA1 HELLS | 6.58e-07 | 390 | 142 | 11 | 17643375 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 6.62e-07 | 5 | 142 | 3 | 2277065 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 6.62e-07 | 5 | 142 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 6.62e-07 | 5 | 142 | 3 | 12919077 | |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 6196357 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CYC1 RAD18 SPOUT1 DYNC2H1 PPP1R12A SRPK2 CNTLN RNF14 IPO9 WDHD1 LUC7L2 MICAL3 DYNC1H1 KPNA1 | 7.06e-07 | 670 | 142 | 14 | 22990118 |
| Pubmed | NOP56 ANK3 DSG2 DYNC2H1 BAG2 SPTLC1 SRPK2 EPB41L3 TIMMDC1 DHX9 SARS2 SURF6 MACF1 AKAP13 PRKCI EIF2AK3 SF3B2 TOP2B GOLGB1 HDLBP HELLS | 7.18e-07 | 1487 | 142 | 21 | 33957083 | |
| Pubmed | RAD18 DSG2 PPP1R12A BAG2 SPTLC1 EMILIN3 SRPK2 SRCAP EPB41L3 TRRAP ABCA8 LUC7L2 SURF6 SCAPER MACF1 BICRAL MBD2 KPNA1 | 7.48e-07 | 1116 | 142 | 18 | 31753913 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 7.85e-07 | 179 | 142 | 8 | 36261009 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | CALD1 NOP56 PPP1R12A SRPK2 EPB41L3 PPP2R1A EIF4B SF3B2 DYNC1H1 HDLBP | 7.90e-07 | 317 | 142 | 10 | 17620599 |
| Pubmed | CYC1 DSG2 VPS45 PPP1R12A MED8 WRN SRP68 SRPK2 RDH13 MORC2 ATAD2 TRRAP CIT SURF6 EIF4B KMT2A MACF1 MBD2 GOLGB1 KPNA1 HDLBP | 8.00e-07 | 1497 | 142 | 21 | 31527615 | |
| Pubmed | TPR DSG2 BAG2 SPTLC1 SRP68 CCDC6 PPP2R1A WDHD1 LUC7L2 QARS1 DYNC1H1 | 8.22e-07 | 399 | 142 | 11 | 37536630 | |
| Pubmed | TPR PPP1R12A MED8 BAG2 SRP68 SRPK2 CIT DHX9 PPP2R1A LONP1 IPO9 LUC7L2 EIF4B ACIN1 QARS1 SF3B2 DYNC1H1 HDLBP HELLS | 8.40e-07 | 1247 | 142 | 19 | 27684187 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH2 MYH3 MYH6 MYH7 SLK HIRIP3 CALD1 PPP1R12A CCDC6 TRRAP PRKD3 PPP2R1A SCAPER KMT2A PRKCI PLEC | 1.07e-06 | 910 | 142 | 16 | 36736316 |
| Pubmed | GPHN TPR RAD18 HIRIP3 CCDC6 MORC2 EPB41L3 WNK1 PRKD3 ACIN1 AKAP13 KIF13A | 1.17e-06 | 503 | 142 | 12 | 16964243 | |
| Pubmed | Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism. | 1.23e-06 | 20 | 142 | 4 | 26299309 | |
| Pubmed | TPR NOP56 PPP1R12A SRP68 DHX9 LONP1 LUC7L2 EIF4B ACIN1 PLEC QARS1 SF3B2 DYNC1H1 KPNA1 HDLBP | 1.23e-06 | 809 | 142 | 15 | 32129710 | |
| Pubmed | GPHN TPR CALD1 SRCAP TRRAP WDHD1 PRIM2 ACIN1 QARS1 SF3B2 DYNC1H1 GOLGB1 | 1.24e-06 | 506 | 142 | 12 | 30890647 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NOP56 WDR46 SPTLC1 MORC2 TRRAP DHX9 WDHD1 PRIM2 PRKCI DNAH8 DYNC1H1 TOP2B KPNA1 VCPIP1 | 1.26e-06 | 704 | 142 | 14 | 29955894 |
| Pubmed | ANK3 CLIP2 VPS45 MYRIP SRPK2 CCDC6 CIT ODF2L SARS2 SURF6 MACF1 PLEC MORC3 QARS1 SF3B2 DYNC1H1 JPH3 KPNA1 VCPIP1 | 1.31e-06 | 1285 | 142 | 19 | 35914814 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 28381556 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.32e-06 | 6 | 142 | 3 | 10077619 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RAD18 RNF168 HIRIP3 WRN SRCAP MORC2 ATAD2 TRRAP KMT2A MORC3 TOP2B KPNA1 HELLS | 1.39e-06 | 608 | 142 | 13 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RAD18 RNF168 HIRIP3 NOP56 BAG2 WRN SRCAP TRRAP DHX9 PPP2R1A LUC7L2 SURF6 KMT2A ACIN1 MBD2 SF3B2 TOP2B VCPIP1 HELLS | 1.45e-06 | 1294 | 142 | 19 | 30804502 |
| Pubmed | TPR NOP56 SPOUT1 DHX9 LUC7L2 CEP135 PLEC SF3B2 DYNC1H1 TOP2B | 1.48e-06 | 340 | 142 | 10 | 29478914 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.52e-06 | 341 | 142 | 10 | 32971831 | |
| Interaction | CHD4 interactions | TPR KRT3 SLK RAD18 NOP56 PPP1R12A BAG2 SRP68 MORC2 CIT ARL4D DHX9 RNF14 ODF2L WDHD1 BRCA2 LUC7L2 KMT2A ACIN1 PRKCI MBD2 SF3B2 TOP2B KPNA1 HDLBP HELLS | 1.86e-09 | 938 | 142 | 26 | int:CHD4 |
| Interaction | KCNA3 interactions | TPR CALD1 NOP56 ANK3 DSG2 MED8 BAG2 SRP68 MORC2 EPB41L3 DHX9 PPP2R1A EIF4B MID1 KMT2A MACF1 MICAL3 POLQ QARS1 EIF2AK3 SF3B2 DYNC1H1 GOLGB1 VCPIP1 HDLBP | 1.97e-09 | 871 | 142 | 25 | int:KCNA3 |
| Interaction | NAA40 interactions | GPHN TPR SLK CALD1 NOP56 DSG2 PPP1R12A SRP68 SRCAP EPB41L3 WNK1 CIT SPAG5 SURF6 EIF4B KMT2A ACIN1 MACF1 CGNL1 SF3B2 TOP2B GOLGB1 VCPIP1 HDLBP HELLS | 2.00e-08 | 978 | 142 | 25 | int:NAA40 |
| Interaction | DYNLL1 interactions | GPHN TPR CLIP2 DYNC2H1 MYO10 PPP1R12A SPTLC1 EPB41L3 CIT SPAG5 PPP2R1A PPP2R1B EIF4B MORC3 QARS1 DYNC1H1 GOLGB1 HDLBP | 2.07e-08 | 510 | 142 | 18 | int:DYNLL1 |
| Interaction | HDAC1 interactions | ANKRD13B TPR MYH2 MYH4 MYH7 MED8 BAG2 WRN CCDC6 USP37 EPB41L3 CIT SPAG5 PPP2R1A PPP2R1B BRCA2 CEP135 KMT2A PLEC MBD2 SF3B2 TOP2B GOLGB1 KPNA1 VCPIP1 HELLS | 5.58e-08 | 1108 | 142 | 26 | int:HDAC1 |
| Interaction | ECT2 interactions | CYC1 RAD18 NOP56 DSG2 PPP1R12A BAG2 SPTLC1 SRP68 SRPK2 TRRAP CIT DHX9 RNF14 IPO9 WDHD1 CEP135 ACIN1 MACF1 MICAL3 PLEC SF3B2 DYNC1H1 TOP2B | 6.15e-08 | 887 | 142 | 23 | int:ECT2 |
| Interaction | EFTUD2 interactions | CYC1 TPR SLK NOP56 BAG2 SRP68 SRPK2 RDH13 USP37 WNK1 CIT SPAG5 DHX9 PPP2R1A LONP1 LUC7L2 PRIM2 EIF4B MACF1 AKAP13 PLEC QARS1 SF3B2 DYNC1H1 TOP2B GOLGB1 KPNA1 VCPIP1 HDLBP HELLS | 7.28e-08 | 1449 | 142 | 30 | int:EFTUD2 |
| Interaction | PHLPP1 interactions | TPR SLK DSG2 BAG2 SRP68 SPAG5 PPP2R1A EIF4B PLEC SF3B2 DYNC1H1 GOLGB1 VCPIP1 HDLBP | 1.03e-07 | 333 | 142 | 14 | int:PHLPP1 |
| Interaction | KCTD13 interactions | NUDT18 CYC1 GPHN CACNA1A MYH6 SLK CALD1 ANK3 CLIP2 VPS45 PPFIA4 PPP1R12A BAG2 SRP68 SRPK2 EPB41L3 CIT DHX9 PPP2R1A LONP1 EIF4B SCAPER KMT2A MACF1 MICAL3 CGNL1 PLEC DYNC1H1 HDLBP | 1.14e-07 | 1394 | 142 | 29 | int:KCTD13 |
| Interaction | YAP1 interactions | GPHN TPR SLK CALD1 NOP56 ANK3 DSG2 PPP1R12A MED8 BAG2 SRP68 CCDC6 SRCAP TRRAP CIT DHX9 PPP2R1A EIF4B KMT2A ACIN1 PLEC SF3B2 DYNC1H1 VCPIP1 HDLBP | 1.76e-07 | 1095 | 142 | 25 | int:YAP1 |
| Interaction | FBXO22 interactions | CYC1 NOP56 ANK3 PPP1R12A BAG2 MORC2 EPB41L3 TRRAP CIT PPP2R1A LUC7L2 SURF6 EIF4B KMT2A MICAL3 QARS1 HELLS | 2.69e-07 | 540 | 142 | 17 | int:FBXO22 |
| Interaction | BAP1 interactions | TPR MYH7 SLK CALD1 NOP56 ANK3 PPP1R12A BAG2 SRP68 SRPK2 CCDC6 DHX9 PPP2R1A IPO9 KRT71 BRCA2 LUC7L2 EIF4B MID1 MACF1 MICAL3 PLEC QARS1 SF3B2 DYNC1H1 KPNA1 HDLBP | 4.31e-07 | 1314 | 142 | 27 | int:BAP1 |
| Interaction | CLASP1 interactions | 5.89e-07 | 138 | 142 | 9 | int:CLASP1 | |
| Interaction | CDC5L interactions | TPR SLK RAD18 BAG2 WRN SRP68 SRPK2 EPB41L3 CIT DHX9 PPP2R1A IPO9 MACF1 BICRAL PLEC SF3B2 RAB27A DYNC1H1 GOLGB1 HDLBP HELLS | 5.99e-07 | 855 | 142 | 21 | int:CDC5L |
| Interaction | PRC1 interactions | CYC1 TPR NOP56 DSG2 PPFIA4 PPP1R12A BAG2 WDR46 TRRAP CIT DHX9 PPP2R1A PPP2R1B LONP1 ACIN1 PLEC QARS1 KIF13A SF3B2 DYNC1H1 TOP2B GOLGB1 | 1.25e-06 | 973 | 142 | 22 | int:PRC1 |
| Interaction | YWHAG interactions | GPHN SLK DSG2 PPP1R12A CNTLN CCDC6 PITPNC1 USP37 EPB41L3 WNK1 TRRAP PPP2R1A IPO9 LUC7L2 EIF4B SIMC1 KMT2A ACIN1 MACF1 AKAP13 PRKCI CGNL1 MORC3 KIF13A DYNC1H1 | 1.96e-06 | 1248 | 142 | 25 | int:YWHAG |
| Interaction | CSNK2B interactions | CACNA1A RAD18 HIRIP3 SPOUT1 GBP2 EPB41L3 ATAD2 PPP2R1A PPP2R1B LUC7L2 SIMC1 KMT2A PRKCI MICAL3 SF3B2 DYNC1H1 TOP2B | 2.01e-06 | 625 | 142 | 17 | int:CSNK2B |
| Interaction | NUP43 interactions | NOP56 PPP1R12A WRN SRCAP MORC2 ATAD2 CIT SPAG5 PPP2R1A FBLN2 BRCA2 LUC7L2 SURF6 KMT2A ACIN1 HPS5 TOP2B | 2.01e-06 | 625 | 142 | 17 | int:NUP43 |
| Interaction | DISC1 interactions | MYH7 CALD1 NOP56 PPFIA4 BAG2 SRP68 EPB41L3 CIT SPAG5 IPO9 CFAP206 MACF1 QARS1 DYNC1H1 | 2.14e-06 | 429 | 142 | 14 | int:DISC1 |
| Interaction | GBF1 interactions | TPR SLK CALD1 DSG2 SRP68 SRPK2 IPO9 SPACA1 MROH2B EIF4B PLEC EIF2AK3 VCPIP1 HDLBP | 3.03e-06 | 442 | 142 | 14 | int:GBF1 |
| Interaction | MKI67 interactions | MYH3 RNF168 NOP56 WDR46 TIGD1 SRPK2 TRRAP CIT ARL4D PPP2R1A LONP1 BRCA2 KMT2A ACIN1 AKAP13 KPNA1 HDLBP | 3.27e-06 | 648 | 142 | 17 | int:MKI67 |
| Interaction | NPM1 interactions | TPR MYH7 RAD18 NOP56 ANK3 PPP1R12A BAG2 JPH2 SRP68 SRPK2 TRRAP CIT ARL4D DHX9 PPP2R1A IPO9 BRCA2 SURF6 MID1 KMT2A PRKCI QARS1 TOP2B KPNA1 | 3.38e-06 | 1201 | 142 | 24 | int:NPM1 |
| Interaction | ACTN2 interactions | 3.51e-06 | 171 | 142 | 9 | int:ACTN2 | |
| Interaction | DOT1L interactions | TPR NOP56 SPOUT1 CLIP2 DSG2 PPP1R12A BAG2 SRP68 SRPK2 ATAD2 TRRAP DHX9 LUC7L2 SURF6 KMT2A ACIN1 QARS1 SF3B2 TOP2B | 4.02e-06 | 807 | 142 | 19 | int:DOT1L |
| Interaction | SUMO2 interactions | TPR RNF168 WRN SRP68 SRCAP ABCA8 PPP2R1A WDHD1 SIMC1 ACIN1 PLEC MORC3 SF3B2 DYNC1H1 TOP2B HDLBP | 4.36e-06 | 591 | 142 | 16 | int:SUMO2 |
| Interaction | USP7 interactions | NLRP11 TPR MYH3 RAD18 RNF168 MYO10 PPP1R12A SRP68 CNTLN CCDC6 TRRAP DHX9 PPP2R1A EIF4B MMRN2 MACF1 PRKCI CGNL1 PLEC KIF13A SF3B2 DYNC1H1 TOP2B GOLGB1 KPNA1 | 4.82e-06 | 1313 | 142 | 25 | int:USP7 |
| Interaction | OBSL1 interactions | TPR CALD1 NOP56 DSG2 BAG2 WDR46 SRCAP TRRAP CIT DHX9 PPP2R1A ACIN1 MACF1 PLEC POLQ SF3B2 DYNC1H1 TOP2B GOLGB1 HDLBP | 5.38e-06 | 902 | 142 | 20 | int:OBSL1 |
| Interaction | ASAH2 interactions | 6.74e-06 | 6 | 142 | 3 | int:ASAH2 | |
| Interaction | CDK9 interactions | TPR HIRIP3 MYO10 PPP1R12A SRP68 SRPK2 SRCAP TRRAP CIT DHX9 PPP2R1A BRCA2 SCAPER KMT2A ACIN1 PLEC SF3B2 | 6.81e-06 | 685 | 142 | 17 | int:CDK9 |
| Interaction | GLYR1 interactions | 7.71e-06 | 239 | 142 | 10 | int:GLYR1 | |
| Interaction | DDX23 interactions | SLK RAD18 NOP56 SRPK2 MORC2 TRRAP CIT WDHD1 SURF6 ACIN1 PRKCI TOP2B HDLBP HELLS | 7.78e-06 | 480 | 142 | 14 | int:DDX23 |
| Interaction | YWHAB interactions | SLK DSG2 PPP1R12A SRPK2 CNTLN CCDC6 PITPNC1 EPB41L3 WNK1 TRRAP DHX9 PPP2R1A IPO9 EIF4B KMT2A MACF1 AKAP13 PRKCI CGNL1 MORC3 DYNC1H1 | 8.73e-06 | 1014 | 142 | 21 | int:YWHAB |
| Interaction | WWTR1 interactions | GPHN SLK CALD1 ANK3 DSG2 PPP1R12A SRP68 SRCAP TRRAP PPP2R1A KMT2A VCPIP1 HDLBP | 9.35e-06 | 422 | 142 | 13 | int:WWTR1 |
| Interaction | DYNC1H1 interactions | TPR SLK RAD18 SPTLC1 TRRAP CIT PPP2R1A LONP1 BRCA2 LUC7L2 EIF4B SF3B2 DYNC1H1 HDLBP | 1.00e-05 | 491 | 142 | 14 | int:DYNC1H1 |
| Interaction | GTF3C4 interactions | 1.02e-05 | 195 | 142 | 9 | int:GTF3C4 | |
| Interaction | CTNNBL1 interactions | 1.11e-05 | 197 | 142 | 9 | int:CTNNBL1 | |
| Interaction | YWHAQ interactions | TPR MYH2 MYH7 SLK DSG2 PPP1R12A CCDC6 EPB41L3 WNK1 DHX9 IPO9 WDHD1 LUC7L2 EIF4B KMT2A MACF1 AKAP13 PRKCI CGNL1 PLEC DYNC1H1 GOLGB1 | 1.16e-05 | 1118 | 142 | 22 | int:YWHAQ |
| Interaction | CSNK2A1 interactions | RAD18 HIRIP3 CALD1 NOP56 CCDC6 MORC2 EPB41L3 ATAD2 TRRAP CIT LUC7L2 SURF6 EIF4B KMT2A ACIN1 MACF1 PRKCI SF3B2 KPNA1 HDLBP | 1.26e-05 | 956 | 142 | 20 | int:CSNK2A1 |
| Interaction | PFN1 interactions | GPHN TPR SRPK2 CCDC6 WNK1 SPAG5 MACF1 AKAP13 MICAL3 QARS1 KIF13A SF3B2 GOLGB1 VCPIP1 | 1.50e-05 | 509 | 142 | 14 | int:PFN1 |
| Interaction | FBXO42 interactions | CNTLN CCDC6 WNK1 DHX9 PPP2R1A ODF2L MACF1 GOLGB1 VCPIP1 HDLBP | 1.55e-05 | 259 | 142 | 10 | int:FBXO42 |
| Interaction | TNIK interactions | CACNA1A TPR NOP56 ANK3 BAG2 STYK1 CIT PPP2R1A LONP1 MACF1 DYNC1H1 HDLBP | 1.68e-05 | 381 | 142 | 12 | int:TNIK |
| Interaction | BRCA2 interactions | RNF168 SRCAP TRRAP WDHD1 BRCA2 SNX32 CEP135 KMT2A ACIN1 PLEC POLQ DYNC1H1 | 1.82e-05 | 384 | 142 | 12 | int:BRCA2 |
| Interaction | H3C1 interactions | TPR RAD18 ANK3 DYNC2H1 WDR46 CCDC6 SRCAP MORC2 ATAD2 TRRAP LUC7L2 KMT2A MORC3 MBD2 DNAH8 SF3B2 DYNC1H1 TOP2B HELLS | 1.91e-05 | 901 | 142 | 19 | int:H3C1 |
| Interaction | SIRT7 interactions | TPR NOP56 WDR46 SRP68 EPB41L3 ATAD2 TRRAP PPP2R1A LONP1 SURF6 KMT2A ACIN1 MACF1 PLEC SF3B2 DYNC1H1 HDLBP | 1.98e-05 | 744 | 142 | 17 | int:SIRT7 |
| Interaction | SNW1 interactions | TPR RAD18 BAG2 SRP68 CIT DHX9 PPP2R1A PPP2R1B IPO9 LUC7L2 KMT2A ACIN1 PLEC SF3B2 KPNA1 HDLBP HELLS | 2.09e-05 | 747 | 142 | 17 | int:SNW1 |
| Interaction | EED interactions | TPR NOP56 SPOUT1 DSG2 VPS45 BAG2 WDR46 SRP68 SRPK2 ATAD2 TRRAP CIT DHX9 PPP2R1A IPO9 ACIN1 MACF1 CGNL1 PLEC MORC3 MBD2 DYNC1H1 KPNA1 HDLBP HELLS | 2.48e-05 | 1445 | 142 | 25 | int:EED |
| Interaction | AURKB interactions | CYC1 NOP56 PPP1R12A BAG2 USP37 WNK1 TRRAP CIT SPAG5 DHX9 PPP2R1A LONP1 BRCA2 SURF6 MACF1 PLEC DYNC1H1 | 2.64e-05 | 761 | 142 | 17 | int:AURKB |
| Interaction | SNAPIN interactions | 2.68e-05 | 169 | 142 | 8 | int:SNAPIN | |
| Interaction | CUL7 interactions | TPR CALD1 NOP56 DSG2 BAG2 EPB41L3 CIT DHX9 PPP2R1A LONP1 ACIN1 MACF1 PLEC QARS1 SF3B2 DYNC1H1 TOP2B GOLGB1 | 2.82e-05 | 845 | 142 | 18 | int:CUL7 |
| Interaction | E2F4 interactions | NOP56 ANK3 SPOUT1 BAG2 JPH2 ATAD2 TRRAP PPP2R1A LONP1 SARS2 LUC7L2 KMT2A ACIN1 MICAL3 | 2.89e-05 | 540 | 142 | 14 | int:E2F4 |
| Interaction | MYH3 interactions | 3.22e-05 | 52 | 142 | 5 | int:MYH3 | |
| Interaction | TAF15 interactions | CACNA1A TPR RNF168 CALD1 PPP1R12A CIT ARL4D DHX9 ACIN1 SF3B2 TOP2B HDLBP | 3.29e-05 | 408 | 142 | 12 | int:TAF15 |
| Interaction | SRPK1 interactions | RAD18 HIRIP3 SRP68 SRPK2 CIT DHX9 LUC7L2 SURF6 CEP135 ACIN1 SF3B2 HDLBP HELLS | 3.38e-05 | 477 | 142 | 13 | int:SRPK1 |
| Interaction | RHOA interactions | CYC1 SLK ANK3 DSG2 VPS45 PPP1R12A SPTLC1 EPB41L3 ATAD2 TRRAP CIT PCDH17 LONP1 IPO9 LUC7L2 MACF1 AKAP13 PRKCI EIF2AK3 TOP2B GOLGB1 KPNA1 | 3.40e-05 | 1199 | 142 | 22 | int:RHOA |
| Interaction | RFC4 interactions | 3.40e-05 | 227 | 142 | 9 | int:RFC4 | |
| Interaction | HIRIP3 interactions | 3.48e-05 | 87 | 142 | 6 | int:HIRIP3 | |
| Interaction | ARGLU1 interactions | 3.58e-05 | 176 | 142 | 8 | int:ARGLU1 | |
| Interaction | SRRM1 interactions | CALD1 SPOUT1 SRPK2 EPB41L3 CIT ACIN1 AKAP13 SF3B2 DYNC1H1 TOP2B HDLBP | 3.70e-05 | 348 | 142 | 11 | int:SRRM1 |
| Interaction | KIF5B interactions | SLK RNF168 SRP68 CCDC6 DHX9 PPP2R1A COG6 EIF4B PRKCI DYNC1H1 HDLBP | 3.70e-05 | 348 | 142 | 11 | int:KIF5B |
| Interaction | DNAJC8 interactions | 3.77e-05 | 230 | 142 | 9 | int:DNAJC8 | |
| Interaction | FLNC interactions | 4.31e-05 | 234 | 142 | 9 | int:FLNC | |
| Interaction | ESF1 interactions | 4.54e-05 | 182 | 142 | 8 | int:ESF1 | |
| Interaction | MECOM interactions | CYC1 TPR MYH2 MYH4 MYH7 NOP56 BAG2 EPB41L3 PLEC DYNC1H1 HELLS | 4.78e-05 | 358 | 142 | 11 | int:MECOM |
| Interaction | BRD3 interactions | RAD18 NOP56 BAG2 SRPK2 EPB41L3 ATAD2 CIT LUC7L2 SURF6 KMT2A ACIN1 TOP2B HELLS | 4.84e-05 | 494 | 142 | 13 | int:BRD3 |
| Interaction | DHX15 interactions | RNF168 NOP56 SRPK2 USP37 EPB41L3 TRRAP CIT PPP2R1A ACIN1 QARS1 SF3B2 DYNC1H1 HDLBP | 5.70e-05 | 502 | 142 | 13 | int:DHX15 |
| Interaction | NKRF interactions | 5.96e-05 | 244 | 142 | 9 | int:NKRF | |
| Interaction | SRPK3 interactions | 6.16e-05 | 190 | 142 | 8 | int:SRPK3 | |
| Interaction | H2AZ1 interactions | RAD18 RNF168 USP37 SRCAP TRRAP CIT IPO9 MBD2 DYNC1H1 TOP2B KPNA1 | 6.58e-05 | 371 | 142 | 11 | int:H2AZ1 |
| Interaction | LINC01554 interactions | 6.69e-05 | 142 | 142 | 7 | int:LINC01554 | |
| Interaction | RHOC interactions | SLK RNF168 DSG2 VPS45 SPTLC1 CIT PCDH17 LONP1 KMT2A MACF1 PRKCI EIF2AK3 GOLGB1 KPNA1 | 6.72e-05 | 584 | 142 | 14 | int:RHOC |
| Interaction | AKAP17A interactions | 7.20e-05 | 99 | 142 | 6 | int:AKAP17A | |
| Interaction | MAPRE1 interactions | CLIP2 MYO10 PPP1R12A BAG2 SRP68 SRPK2 SPAG5 EIF4B CEP135 MACF1 PLEC QARS1 DYNC1H1 | 7.24e-05 | 514 | 142 | 13 | int:MAPRE1 |
| Interaction | THRAP3 interactions | RAD18 MYO10 SRPK2 CIT ARL4D DHX9 BRCA2 LUC7L2 ACIN1 PLEC SF3B2 HDLBP | 7.26e-05 | 443 | 142 | 12 | int:THRAP3 |
| Interaction | POLN interactions | 7.29e-05 | 32 | 142 | 4 | int:POLN | |
| Interaction | PSPC1 interactions | NOP56 PPP1R12A SRP68 SRPK2 MORC2 TRRAP CIT DHX9 EIF4B QARS1 SF3B2 TOP2B HDLBP | 7.38e-05 | 515 | 142 | 13 | int:PSPC1 |
| Interaction | SLFN11 interactions | TPR MYH2 RNF168 NOP56 TRRAP DHX9 PPP2R1A EIF4B POLQ VCPIP1 HDLBP | 7.42e-05 | 376 | 142 | 11 | int:SLFN11 |
| Interaction | CIT interactions | CYC1 TPR NOP56 SPOUT1 DSG2 DYNC2H1 PPP1R12A BAG2 SRP68 TRRAP CIT DHX9 PPP2R1A LONP1 MROH2B KMT2A ACIN1 MACF1 PLEC QARS1 SF3B2 DYNC1H1 TOP2B HDLBP | 7.43e-05 | 1450 | 142 | 24 | int:CIT |
| Interaction | SNRPB interactions | SRPK2 EPB41L3 CIT DHX9 PPP2R1A COG6 ACIN1 MACF1 MICAL3 QARS1 SF3B2 DYNC1H1 HDLBP | 7.67e-05 | 517 | 142 | 13 | int:SNRPB |
| Interaction | RBMX2 interactions | 8.05e-05 | 101 | 142 | 6 | int:RBMX2 | |
| Interaction | APEX1 interactions | RAD18 NOP56 CLIP2 PPP1R12A WDR46 SRPK2 SRCAP MORC2 NKIRAS1 TRRAP ODF2L SARS2 ABCB9 BRCA2 SURF6 ABTB1 KMT2A QARS1 KIF13A TOP2B KPNA1 HELLS | 8.08e-05 | 1271 | 142 | 22 | int:APEX1 |
| Interaction | TOP2A interactions | RAD18 RNF168 NOP56 SRP68 SRPK2 CIT DHX9 BRCA2 PRIM2 SF3B2 DYNC1H1 TOP2B KPNA1 | 8.13e-05 | 520 | 142 | 13 | int:TOP2A |
| Interaction | MYH9 interactions | RAD18 CALD1 DSG2 PPP1R12A WNK1 TRRAP CIT PPP2R1A ODF2L LUC7L2 EIF4B MACF1 PRKCI MICAL3 PLEC MBD2 | 8.47e-05 | 754 | 142 | 16 | int:MYH9 |
| Interaction | WDR76 interactions | NOP56 BAG2 EMILIN3 ATAD2 TRRAP DHX9 PPP2R1A LONP1 PLEC QARS1 HELLS | 8.74e-05 | 383 | 142 | 11 | int:WDR76 |
| Interaction | TRIM33 interactions | SLK BAG2 SRP68 TRRAP DHX9 IPO9 EIF4B QARS1 SF3B2 GOLGB1 KPNA1 HDLBP | 8.96e-05 | 453 | 142 | 12 | int:TRIM33 |
| Interaction | BOD1L1 interactions | 9.06e-05 | 149 | 142 | 7 | int:BOD1L1 | |
| Interaction | TMEM260 interactions | 9.30e-05 | 13 | 142 | 3 | int:TMEM260 | |
| Interaction | FBXO32 interactions | MYH3 MYH4 MYH6 NOP56 SPTLC1 FBLN2 IPO9 PRIM2 EIF4B PLEC HELLS | 9.36e-05 | 386 | 142 | 11 | int:FBXO32 |
| Interaction | RTF1 interactions | 9.45e-05 | 150 | 142 | 7 | int:RTF1 | |
| Interaction | SSRP1 interactions | RAD18 HIRIP3 NOP56 TRRAP CIT DHX9 PPP2R1B WDHD1 BRCA2 PRIM2 KMT2A ACIN1 MORC3 TOP2B HDLBP | 1.01e-04 | 685 | 142 | 15 | int:SSRP1 |
| Interaction | CFTR interactions | TPR MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 PPP1R12A BAG2 SPTLC1 SRP68 TOR4A RDH13 FGL2 PPP2R1A PPP2R1B IPO9 COG6 MACF1 PLEC QARS1 SF3B2 DYNC1H1 HDLBP | 1.02e-04 | 1480 | 142 | 24 | int:CFTR |
| Interaction | EBNA1BP2 interactions | 1.03e-04 | 324 | 142 | 10 | int:EBNA1BP2 | |
| Interaction | TJP1 interactions | 1.05e-04 | 325 | 142 | 10 | int:TJP1 | |
| Interaction | TAF1C interactions | 1.17e-04 | 108 | 142 | 6 | int:TAF1C | |
| Interaction | PRPF38B interactions | 1.17e-04 | 108 | 142 | 6 | int:PRPF38B | |
| Interaction | PRKAG2 interactions | 1.18e-04 | 68 | 142 | 5 | int:PRKAG2 | |
| Interaction | PPP1CB interactions | SLK RAD18 CALD1 PPP1R12A USP37 CIT DHX9 EIF4B PRKCI PLEC DYNC1H1 HDLBP | 1.24e-04 | 469 | 142 | 12 | int:PPP1CB |
| Interaction | YWHAZ interactions | SLK CLIP2 DSG2 PPP1R12A CCDC6 PITPNC1 EPB41L3 WNK1 SPAG5 PPP2R1A IPO9 EIF4B SIMC1 KMT2A MACF1 AKAP13 PRKCI CGNL1 PLEC MORC3 SF3B2 DYNC1H1 | 1.38e-04 | 1319 | 142 | 22 | int:YWHAZ |
| Interaction | TRIP12 interactions | 1.41e-04 | 214 | 142 | 8 | int:TRIP12 | |
| Interaction | CDC42 interactions | ANK3 DSG2 DYNC2H1 VPS45 PPP1R12A WRN SPTLC1 EPB41L3 WNK1 TRRAP CIT PCDH17 DHX9 PPP2R1A LONP1 IPO9 PRKCI EIF2AK3 TOP2B GOLGB1 KPNA1 HDLBP | 1.44e-04 | 1323 | 142 | 22 | int:CDC42 |
| Interaction | MYO18B interactions | 1.46e-04 | 15 | 142 | 3 | int:MYO18B | |
| GeneFamily | Myosin heavy chains | 1.64e-08 | 15 | 104 | 5 | 1098 | |
| GeneFamily | Protein phosphatase 2 scaffold subunits|STRIPAK complex | 3.28e-05 | 2 | 104 | 2 | 1266 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.01e-04 | 23 | 104 | 3 | 662 | |
| GeneFamily | EMI domain containing | 6.75e-04 | 7 | 104 | 2 | 540 | |
| GeneFamily | Zinc fingers CW-type | 6.75e-04 | 7 | 104 | 2 | 96 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.97e-04 | 8 | 104 | 2 | 939 | |
| GeneFamily | ATP binding cassette subfamily B | 1.74e-03 | 11 | 104 | 2 | 806 | |
| GeneFamily | Dyneins, cytoplasmic | 2.45e-03 | 13 | 104 | 2 | 538 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.72e-03 | 18 | 104 | 2 | 596 | |
| GeneFamily | Ring finger proteins | 5.13e-03 | 275 | 104 | 6 | 58 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 5.82e-03 | 20 | 104 | 2 | 1371 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK MYO10 PPP1R12A WRN SRPK2 CCDC6 TRRAP WDHD1 BRCA2 PRIM2 MID1 CEP135 MACF1 AKAP13 PRKCI MICAL3 BICRAL MBD2 TRIM44 | 2.00e-07 | 856 | 142 | 19 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | RNF168 HIRIP3 CNTLN ATAD2 CIT SLC2A5 SPAG5 WDHD1 BRCA2 PRIM2 PRKCI GNA15 HELLS | 2.16e-06 | 478 | 142 | 13 | M45785 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLK RAD18 CALD1 MYO10 WRN EPB41L3 ATAD2 WDHD1 COG6 MID1 POLQ RAB27A TOP2B GOLGB1 HELLS | 2.94e-06 | 656 | 142 | 15 | M18979 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ANKRD13B RAD18 HIRIP3 CHGB USP37 ATAD2 SPAG5 DHX9 ODF2L WDHD1 BRCA2 PRIM2 SIMC1 SCN8A HELLS | 4.54e-06 | 680 | 142 | 15 | MM456 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPR MYH6 CALD1 ANK3 TCIM WRN GBP2 SPAG5 FGL2 PRKD3 RNF14 FBLN2 PLEC SF3B2 HDLBP | 5.41e-06 | 690 | 142 | 15 | M12224 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | RAD18 RNF168 HIRIP3 BAG2 CNTLN USP37 ATAD2 SPAG5 WDHD1 BRCA2 PRIM2 SIMC1 POLQ RAB27A HELLS | 5.80e-06 | 694 | 142 | 15 | M45767 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SLK MYO10 PPP1R12A WRN SRPK2 TRRAP PRIM2 MID1 CEP135 PRKCI MICAL3 MBD2 | 9.36e-06 | 466 | 142 | 12 | M13522 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 9.74e-06 | 90 | 142 | 6 | M39250 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | TPR MYH6 CALD1 ANK3 TCIM WRN GBP2 SPAG5 FGL2 PRKD3 RNF14 FBLN2 PLEC SF3B2 HDLBP | 1.26e-05 | 741 | 142 | 15 | MM1037 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | RAD18 DSG2 ATAD2 CIT SPAG5 ODF2L WDHD1 BRCA2 PRIM2 POLQ HELLS | 1.28e-05 | 402 | 142 | 11 | MM454 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | RAD18 HIRIP3 STYK1 RGS9 ATAD2 CIT WDHD1 BRCA2 PRIM2 MID1 CEP135 MICAL3 POLQ | 1.98e-05 | 588 | 142 | 13 | M38992 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | RAD18 HIRIP3 SPOUT1 BAG2 SRP68 CNTLN ATAD2 CIT SPAG5 ARL4D PPP2R1B FBLN2 IPO9 SARS2 WDHD1 BRCA2 PRIM2 CEP135 SCAPER POLQ HELLS | 2.77e-05 | 1423 | 142 | 21 | M45722 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.87e-05 | 221 | 142 | 8 | M39222 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 3.49e-05 | 166 | 142 | 7 | M6826 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 4.22e-05 | 171 | 142 | 7 | M39234 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | RNF168 HIRIP3 BAG2 CNTLN USP37 ATAD2 CIT SPAG5 ARL4D FBLN2 WDHD1 BRCA2 PRIM2 CEP135 POLQ HELLS | 5.18e-05 | 939 | 142 | 16 | M45768 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 5.84e-05 | 180 | 142 | 7 | M8127 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.84e-05 | 180 | 142 | 7 | M8239 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | TPR MYO10 CCDC6 WNK1 DHX9 MACF1 PRKCI HPS5 MBD2 TRIM44 TOP2B | 6.53e-05 | 481 | 142 | 11 | M3898 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CYC1 RAD18 CALD1 NOP56 DSG2 WRN LAMA4 EPB41L3 ATAD2 TIMMDC1 PCDH17 SPAG5 IPO9 WDHD1 BRCA2 LUC7L2 PRIM2 CEP135 POLQ HELLS | 7.37e-05 | 1407 | 142 | 20 | M14427 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | CYC1 HIRIP3 DSG2 WDR46 SRPK2 SPAG5 DHX9 PPP2R1B WDHD1 LUC7L2 ACIN1 POLQ HELLS | 7.43e-05 | 669 | 142 | 13 | M18635 |
| Coexpression | FISCHER_DREAM_TARGETS | RAD18 HIRIP3 WDR46 WRN USP37 ATAD2 CIT SPAG5 LONP1 WDHD1 BRCA2 PRIM2 CEP135 POLQ EIF2AK3 HELLS | 7.50e-05 | 969 | 142 | 16 | M149 |
| Coexpression | E2F1_UP.V1_UP | 7.68e-05 | 188 | 142 | 7 | M2632 | |
| Coexpression | GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 8.21e-05 | 190 | 142 | 7 | M8190 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 8.87e-05 | 133 | 142 | 6 | M8880 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 9.66e-05 | 195 | 142 | 7 | M9808 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 1.04e-04 | 137 | 142 | 6 | M406 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.04e-04 | 137 | 142 | 6 | MM990 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP | 1.10e-04 | 199 | 142 | 7 | M9600 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP | 1.13e-04 | 200 | 142 | 7 | M9542 | |
| Coexpression | GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP | 1.13e-04 | 200 | 142 | 7 | M9608 | |
| Coexpression | GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN | 1.13e-04 | 200 | 142 | 7 | M3435 | |
| Coexpression | HALLMARK_E2F_TARGETS | 1.13e-04 | 200 | 142 | 7 | M5925 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR MYH3 MYH6 CALD1 ANK3 MYO10 WRN TIMMDC1 FBLN2 KRT71 PLEC SF3B2 | 1.26e-04 | 610 | 142 | 12 | M3854 |
| Coexpression | WHITFIELD_CELL_CYCLE_S | 1.72e-04 | 150 | 142 | 6 | M2075 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | TPR MYH3 MYH6 CALD1 ANK3 MYO10 WRN TIMMDC1 FBLN2 KRT71 PLEC SF3B2 | 2.27e-04 | 650 | 142 | 12 | MM1042 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 2.67e-04 | 230 | 142 | 7 | M11563 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | RAD18 MYO10 WRN LAMA4 EMILIN3 SRPK2 EPB41L3 PCDH17 PRKCI CGNL1 TRIM44 TOP2B HDLBP | 2.76e-06 | 397 | 142 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | TPR ANK3 MYO10 WRN LAMA4 EMILIN3 EPB41L3 PCDH17 SPAG5 TRIM44 SF3B2 TOP2B | 7.28e-06 | 369 | 142 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 7.39e-06 | 149 | 142 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR ANK3 MYO10 LAMA4 EMILIN3 EPB41L3 WNK1 PCDH17 SCAPER KIF13A TRIM44 HDLBP | 1.11e-05 | 385 | 142 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | MYH3 ANK3 MYO10 PPP1R12A LAMA4 EPB41L3 ATAD2 EIF4B MID1 SCN8A AKAP13 QARS1 MBD2 TRIM44 SF3B2 TOP2B HDLBP | 2.38e-05 | 795 | 142 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | RAD18 CALD1 DSG2 MYO10 PPP1R12A WRN LAMA4 JPH2 EMILIN3 SRPK2 EPB41L3 PCDH17 PRKCI CGNL1 TRIM44 TOP2B HDLBP | 3.06e-05 | 811 | 142 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | TPR CALD1 CNTLN BRCA2 MID1 CEP135 SCAPER MACF1 RAB27A GOLGB1 | 3.32e-05 | 298 | 142 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GPHN CACNA1A RNF168 HIRIP3 DYNC2H1 MYO10 SRPK2 CIT SPAG5 RNF14 ODF2L BRCA2 CEP135 MICAL3 POLQ EIF2AK3 TOP2B | 4.15e-05 | 831 | 142 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.05e-05 | 101 | 142 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 6.37e-05 | 201 | 142 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | RAD18 CALD1 PPP1R12A LAMA4 JPH2 EMILIN3 EPB41L3 ATAD2 PCDH17 TOP2B HDLBP | 6.94e-05 | 393 | 142 | 11 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ANKRD13B TPR RAD18 RNF168 HIRIP3 NOP56 MYO10 WDR46 PGBD1 CNTLN ATAD2 CIT SPAG5 ODF2L BRCA2 PRIM2 MID1 CEP135 SCN8A MACF1 HELLS | 9.47e-05 | 1257 | 142 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR CALD1 ANK3 MYO10 PPP1R12A WRN LAMA4 JPH2 EMILIN3 CHGB EPB41L3 PCDH17 SPAG5 TRIM44 SF3B2 TOP2B | 1.00e-04 | 806 | 142 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR ANK3 DSG2 MYO10 PPP1R12A MYRIP LAMA4 EMILIN3 CHGB EPB41L3 WNK1 PCDH17 SCAPER KIF13A TRIM44 HDLBP | 1.19e-04 | 818 | 142 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR SLK RNF168 PPP1R12A CNTLN WNK1 CIT BRCA2 MACF1 RAB27A GOLGB1 | 1.60e-04 | 432 | 142 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.52e-04 | 311 | 142 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.58e-04 | 312 | 142 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_200 | 2.62e-04 | 19 | 142 | 3 | gudmap_developingGonad_e14.5_ epididymis_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.15e-04 | 192 | 142 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SLK RNF168 DYNC2H1 PPP1R12A CNTLN WNK1 CIT ODF2L SARS2 BRCA2 MACF1 RAB27A GOLGB1 | 3.16e-04 | 629 | 142 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MYH6 RAD18 CALD1 MYO10 CHGB SRCAP PPP2R1A FBLN2 LUC7L2 MID1 MMRN2 ACIN1 PLEC VCPIP1 HELLS | 3.34e-04 | 806 | 142 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 3.36e-04 | 194 | 142 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.91e-04 | 142 | 142 | 6 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | TPR MYH3 MYH7 ANK3 MYO10 LAMA4 EMILIN3 EPB41L3 PCDH17 TRIM44 | 4.22e-04 | 407 | 142 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 4.38e-04 | 409 | 142 | 10 | GSM399452_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.53e-04 | 146 | 142 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TPR RAB9B CALD1 LAMA4 EMILIN3 CNTLN EPB41L3 FBLN2 BRCA2 CEP135 SCAPER MACF1 AKAP13 MBD2 | 4.76e-04 | 744 | 142 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | ANK3 MYO10 PPP1R12A MYRIP LAMA4 CHGB EPB41L3 PCDH17 TRIM44 HDLBP | 5.00e-04 | 416 | 142 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 5.24e-04 | 209 | 142 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | MYH2 MYH3 MYH6 MYH7 CALD1 PPP1R12A PARP3 BAG2 LAMA4 JPH2 SRPK2 PCDH17 ARL4D RAB27A | 5.94e-04 | 761 | 142 | 14 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 6.15e-04 | 58 | 142 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_200 | 6.54e-04 | 6 | 142 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SLK RNF168 DYNC2H1 PPP1R12A SRCAP WNK1 ODF2L SARS2 MACF1 RAB27A DYNC1H1 GOLGB1 | 6.68e-04 | 595 | 142 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ANKRD13B TPR RAD18 RNF168 HIRIP3 NOP56 MYO10 WDR46 PGBD1 CNTLN ATAD2 CIT SPAG5 ODF2L BRCA2 PRIM2 MID1 CEP135 SCN8A MACF1 HELLS | 7.05e-04 | 1459 | 142 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-08 | 190 | 142 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1A DYNC2H1 MYO10 EPB41L3 SCAPER KMT2A MACF1 DYNC1H1 GOLGB1 | 1.36e-08 | 195 | 142 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-08 | 196 | 142 | 9 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.70e-08 | 200 | 142 | 9 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.47e-07 | 185 | 142 | 8 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-07 | 191 | 142 | 8 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-07 | 192 | 142 | 8 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.04e-07 | 193 | 142 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.12e-07 | 194 | 142 | 8 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 195 | 142 | 8 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 195 | 142 | 8 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 195 | 142 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-07 | 195 | 142 | 8 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 2.29e-07 | 196 | 142 | 8 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 2.38e-07 | 197 | 142 | 8 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 2.38e-07 | 197 | 142 | 8 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 2.47e-07 | 198 | 142 | 8 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 2.47e-07 | 198 | 142 | 8 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.57e-07 | 199 | 142 | 8 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-07 | 199 | 142 | 8 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.57e-07 | 199 | 142 | 8 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 2.57e-07 | 199 | 142 | 8 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-07 | 199 | 142 | 8 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-07 | 200 | 142 | 8 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 2.67e-07 | 200 | 142 | 8 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 2.67e-07 | 200 | 142 | 8 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.67e-07 | 200 | 142 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-07 | 200 | 142 | 8 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.67e-07 | 200 | 142 | 8 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-07 | 200 | 142 | 8 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.67e-07 | 200 | 142 | 8 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-07 | 200 | 142 | 8 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.67e-07 | 200 | 142 | 8 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.67e-07 | 200 | 142 | 8 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 167 | 142 | 7 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 169 | 142 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-06 | 171 | 142 | 7 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-06 | 172 | 142 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 173 | 142 | 7 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 173 | 142 | 7 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-06 | 174 | 142 | 7 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-06 | 177 | 142 | 7 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.98e-06 | 182 | 142 | 7 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.06e-06 | 183 | 142 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-06 | 184 | 142 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-06 | 184 | 142 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.13e-06 | 184 | 142 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.13e-06 | 184 | 142 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.13e-06 | 184 | 142 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.64e-06 | 190 | 142 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 192 | 142 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-06 | 193 | 142 | 7 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-06 | 194 | 142 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.02e-06 | 194 | 142 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-06 | 194 | 142 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-06 | 194 | 142 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 3.13e-06 | 195 | 142 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.24e-06 | 196 | 142 | 7 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 3.35e-06 | 197 | 142 | 7 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 3.35e-06 | 197 | 142 | 7 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 3.35e-06 | 197 | 142 | 7 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.46e-06 | 198 | 142 | 7 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | severe_influenza-T/NK_proliferative|severe_influenza / disease group, cell group and cell class (v2) | 3.58e-06 | 199 | 142 | 7 | 638b1491c47f2884daf1c1d38a779ad8e0f59c52 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 3.58e-06 | 199 | 142 | 7 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 3.58e-06 | 199 | 142 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 3.58e-06 | 199 | 142 | 7 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.58e-06 | 199 | 142 | 7 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 3.58e-06 | 199 | 142 | 7 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 3.58e-06 | 199 | 142 | 7 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 3.58e-06 | 199 | 142 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.70e-06 | 200 | 142 | 7 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.70e-06 | 200 | 142 | 7 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.70e-06 | 200 | 142 | 7 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | severe-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.70e-06 | 200 | 142 | 7 | 9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 3.70e-06 | 200 | 142 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 3.70e-06 | 200 | 142 | 7 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.70e-06 | 200 | 142 | 7 | 1da366e35a05f73253629663eeea1fed4ebd7b52 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.70e-06 | 200 | 142 | 7 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.70e-06 | 200 | 142 | 7 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.70e-06 | 200 | 142 | 7 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.70e-06 | 200 | 142 | 7 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | severe-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.70e-06 | 200 | 142 | 7 | d341f4e500377a5bef82c24bf64704b981053336 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.70e-06 | 200 | 142 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.70e-06 | 200 | 142 | 7 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.70e-06 | 200 | 142 | 7 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-SEP / Disease, condition lineage and cell class | 3.70e-06 | 200 | 142 | 7 | ae500c8b7c2162cadd31bf44ee9dc3271192cf17 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.70e-06 | 200 | 142 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 3.70e-06 | 200 | 142 | 7 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 139 | 142 | 6 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 156 | 142 | 6 | 1928c86deb3bcd01db4ae76919a351066aadb39a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 165 | 142 | 6 | 9de841c1c95967c562720feba930246debc626fd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.02e-06 | 50 | 96 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | AC1LADJ6 | 9.12e-09 | 130 | 142 | 10 | CID000486032 | |
| Drug | blebbistatin | 4.79e-08 | 116 | 142 | 9 | CID003476986 | |
| Drug | SM-2 | 7.24e-08 | 87 | 142 | 8 | CID000486033 | |
| Drug | purealin | 7.29e-08 | 58 | 142 | 7 | CID006419303 | |
| Drug | testosterone enanthate | TPR MYH3 ANK3 ADAM21 PPP1R12A MED8 WDR46 LAMA4 GBP2 SRPK2 WNK1 PCDH17 KMT2A MACF1 AKAP13 RAB27A | 6.41e-07 | 575 | 142 | 16 | ctd:C004648 |
| Drug | formycin triphosphate | 7.57e-07 | 51 | 142 | 6 | CID000122274 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.82e-06 | 178 | 142 | 9 | 3998_DN | |
| Drug | NSC611747 | MYH2 MYH3 MYH4 MYH6 MYH7 MYO10 PPP1R12A PRKD3 PPP2R1A PPP2R1B AKAP13 PRKCI | 2.23e-06 | 352 | 142 | 12 | CID000002534 |
| Drug | AC1NRBPQ | 2.38e-06 | 137 | 142 | 8 | CID005288569 | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.51e-06 | 185 | 142 | 9 | 1673_DN | |
| Drug | S-(-)-Etomoxir | 3.12e-06 | 100 | 142 | 7 | CID000060765 | |
| Drug | AC1L1IZ2 | MYH2 MYH3 MYH4 MYH6 MYH7 MYO10 WNK1 LONP1 EIF4B DYNC1H1 TOP2B | 3.39e-06 | 304 | 142 | 11 | CID000004795 |
| Drug | NSC107658 | MYH2 MYH3 MYH4 MYH6 MYH7 MYO10 PPP1R12A SLC2A5 FGL2 PRKD3 PRKCI | 3.61e-06 | 306 | 142 | 11 | CID000002919 |
| Drug | fast white | 6.21e-06 | 42 | 142 | 5 | CID000024008 | |
| Drug | NSC226080 | TPR MYH2 MYH3 MYH4 MYH6 MYH7 CCDC6 ARL4D PRKD3 PPP2R1A PPP2R1B EIF4B PRKCI EIF2AK3 GOLGB1 JPH3 KPNA1 | 7.90e-06 | 782 | 142 | 17 | CID000005040 |
| Drug | B0683 | 8.86e-06 | 117 | 142 | 7 | CID006398969 | |
| Drug | nifedipine | CACNA1A MYH2 MYH3 MYH4 MYH6 MYH7 TRPC5 PRKD3 CACNA2D4 PRKCI EIF2AK3 TOP2B | 1.18e-05 | 415 | 142 | 12 | CID000004485 |
| Drug | Razoxane | 1.21e-05 | 48 | 142 | 5 | ctd:D011929 | |
| Drug | verapamil | CACNA1A MYH2 MYH3 MYH4 MYH6 MYH7 ABCA8 ABCB4 PRKD3 CACNA2D4 ABCB9 PRKCI TOP2B | 1.27e-05 | 490 | 142 | 13 | CID000002520 |
| Drug | lithocholyltaurine | 1.45e-05 | 175 | 142 | 8 | CID000010595 | |
| Drug | eye gene | MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 MYO10 PPP1R12A PRKD3 CACNA2D4 PRKCI | 2.10e-05 | 369 | 142 | 11 | CID000004782 |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.25e-05 | 186 | 142 | 8 | 3279_DN | |
| Drug | ilmofosine | 2.28e-05 | 27 | 142 | 4 | CID000055008 | |
| Drug | carbachol | CACNA1A MYH2 MYH3 MYH4 MYH6 MYH7 CALD1 PPP1R12A TRPC5 LAMA4 PRKD3 CACNA2D4 ACIN1 PRKCI GNA15 | 2.70e-05 | 688 | 142 | 15 | CID000002551 |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.83e-05 | 192 | 142 | 8 | 4801_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.05e-05 | 194 | 142 | 8 | 4308_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 3524_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 5288_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 3.28e-05 | 196 | 142 | 8 | 2735_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 1658_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 3438_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.52e-05 | 198 | 142 | 8 | 5916_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.78e-05 | 200 | 142 | 8 | 5931_DN | |
| Drug | 4-chloroaniline | 4.06e-05 | 202 | 142 | 8 | CID000007812 | |
| Drug | AC1N9ZZC | 4.24e-05 | 149 | 142 | 7 | CID004369374 | |
| Drug | nocodazole | GPHN MYH2 MYH3 MYH4 MYH6 MYH7 PPP1R12A MYRIP PPP2R1A PPP2R1B DYNC1H1 GOLGB1 | 4.63e-05 | 477 | 142 | 12 | CID000004122 |
| Drug | Jmv 180 | 9.08e-05 | 38 | 142 | 4 | CID003035023 | |
| Drug | tautomycin | 9.83e-05 | 118 | 142 | 6 | CID000440646 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 1.01e-04 | 39 | 142 | 4 | CID000107855 | |
| Drug | oxovanadium | 1.08e-04 | 120 | 142 | 6 | CID000024411 | |
| Drug | 2bq7 | 1.24e-04 | 123 | 142 | 6 | CID006540267 | |
| Drug | NSC 284682 | 1.25e-04 | 16 | 142 | 3 | CID000072518 | |
| Drug | AC1L1B9H | 1.29e-04 | 78 | 142 | 5 | CID000001341 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.60e-10 | 10 | 135 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.44e-09 | 12 | 135 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.44e-09 | 12 | 135 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.33e-09 | 13 | 135 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.39e-09 | 15 | 135 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.74e-08 | 71 | 135 | 7 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Cardiomyopathy | 2.45e-06 | 47 | 135 | 5 | cv:C0878544 | |
| Disease | myopathy (implicated_via_orthology) | 2.72e-06 | 48 | 135 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | Primary familial dilated cardiomyopathy | 1.05e-05 | 30 | 135 | 4 | cv:C0340427 | |
| Disease | Primary dilated cardiomyopathy | 1.75e-05 | 34 | 135 | 4 | cv:C0007193 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.59e-05 | 13 | 135 | 3 | C0270914 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.40e-05 | 80 | 135 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 4.94e-05 | 44 | 135 | 4 | C0340427 | |
| Disease | EMILIN-3 measurement | 6.21e-05 | 3 | 135 | 2 | EFO_0801563 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.24e-04 | 4 | 135 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.24e-04 | 4 | 135 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 1.24e-04 | 4 | 135 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.24e-04 | 4 | 135 | 2 | 192600 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 1.35e-04 | 22 | 135 | 3 | cv:C0949658 | |
| Disease | Limb-girdle muscular dystrophy | 2.25e-04 | 26 | 135 | 3 | cv:C0686353 | |
| Disease | triacylglycerol 54:7 measurement | 2.82e-04 | 28 | 135 | 3 | EFO_0010425 | |
| Disease | Cardiomyopathies | 3.37e-04 | 130 | 135 | 5 | C0878544 | |
| Disease | triacylglycerol 54:3 measurement | 3.83e-04 | 31 | 135 | 3 | EFO_0010421 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 4.30e-04 | 7 | 135 | 2 | C0700053 | |
| Disease | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0020108 | |
| Disease | Obstructive asymmetric septal hypertrophy | 4.30e-04 | 7 | 135 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 7.32e-04 | 9 | 135 | 2 | C0949658 | |
| Disease | substance abuse, antisocial behaviour measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0007052, MONDO_0002491 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 9.13e-04 | 10 | 135 | 2 | cv:C5675009 | |
| Disease | epilepsy (implicated_via_orthology) | 9.41e-04 | 163 | 135 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | MYH6 RAPSN CALD1 ANK3 CLIP2 DYNC2H1 JPH2 EMILIN3 ODF2L MMRN2 | 1.06e-03 | 670 | 135 | 10 | EFO_0006335, EFO_0006336 |
| Disease | Intellectual Disability | 1.08e-03 | 447 | 135 | 8 | C3714756 | |
| Disease | chronic kidney disease, Proteinuria | 1.11e-03 | 11 | 135 | 2 | EFO_0003884, HP_0000093 | |
| Disease | mean reticulocyte volume | RAPSN RNF168 TRRAP ABCB4 PPP2R1B LONP1 AKAP13 GNA15 MBD2 GOLGB1 HDLBP | 1.15e-03 | 799 | 135 | 11 | EFO_0010701 |
| Disease | ovarian serous carcinoma | 1.23e-03 | 46 | 135 | 3 | EFO_1001516 | |
| Disease | Charcot-Marie-Tooth Disease | 1.33e-03 | 12 | 135 | 2 | C0007959 | |
| Disease | microphthalmia (implicated_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.50e-03 | 702 | 135 | 10 | C0009402 | |
| Disease | serum albumin measurement | 1.66e-03 | 592 | 135 | 9 | EFO_0004535 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.07e-03 | 55 | 135 | 3 | EFO_0004623, HP_0002140 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.10e-03 | 15 | 135 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | P wave duration | 2.10e-03 | 15 | 135 | 2 | EFO_0005094 | |
| Disease | Tremor, Rubral | 2.39e-03 | 16 | 135 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.39e-03 | 16 | 135 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.39e-03 | 16 | 135 | 2 | C0278161 | |
| Disease | 5-oxoproline measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0010988 | |
| Disease | Ataxia, Sensory | 2.39e-03 | 16 | 135 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.39e-03 | 16 | 135 | 2 | C0520966 | |
| Disease | level of Sterol ester (27:1/18:0) in blood serum | 2.39e-03 | 16 | 135 | 2 | OBA_2045196 | |
| Disease | Ataxia, Truncal | 2.39e-03 | 16 | 135 | 2 | C0427190 | |
| Disease | Schizophrenia | ANK3 PGBD1 RGS9 CHGB TRRAP PCDH17 GJA8 KMT2A CGNL1 MBD2 KPNA1 | 2.51e-03 | 883 | 135 | 11 | C0036341 |
| Disease | triacylglycerol 56:9 measurement | 2.70e-03 | 17 | 135 | 2 | EFO_0010436 | |
| Disease | Myeloid Leukemia | 3.03e-03 | 18 | 135 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.03e-03 | 18 | 135 | 2 | C0023466 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.03e-03 | 18 | 135 | 2 | OBA_2045065 | |
| Disease | Grand Mal Status Epilepticus | 3.62e-03 | 67 | 135 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.62e-03 | 67 | 135 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.62e-03 | 67 | 135 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.62e-03 | 67 | 135 | 3 | C0751523 | |
| Disease | Petit mal status | 3.62e-03 | 67 | 135 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.62e-03 | 67 | 135 | 3 | C0393734 | |
| Disease | phosphatidylcholine 34:2 measurement | 3.74e-03 | 20 | 135 | 2 | EFO_0010376 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 3.74e-03 | 20 | 135 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | Status Epilepticus | 3.78e-03 | 68 | 135 | 3 | C0038220 | |
| Disease | Arthrogryposis | 4.12e-03 | 21 | 135 | 2 | C0003886 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.52e-03 | 22 | 135 | 2 | C3711387 | |
| Disease | Primary microcephaly | 4.52e-03 | 22 | 135 | 2 | C0431350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRADRNLKTEEEEEE | 261 | Q9UKV3 | |
| LATVEETVVRDKAVE | 96 | P30153 | |
| ENLATVEETVVRDKA | 106 | P30154 | |
| ISKAEEVILAEDETD | 396 | O00555 | |
| VDAAEAERLEEAKVE | 101 | P49703 | |
| EDNLIEARKEVEVSQ | 286 | Q9NXG0 | |
| ESKIISDVEEQEAAI | 291 | Q9NZJ5 | |
| TEKEVARQQLEFEEA | 176 | Q9UKJ8 | |
| VTVLLAEEDKAEDDV | 16 | Q12802 | |
| KVEDLQFRVEEESIT | 441 | Q9UDT6 | |
| TAEEVKRLEEQEEDT | 971 | Q6PL18 | |
| KASVTIQARAEQEEE | 96 | Q16204 | |
| TEDEAKELAAEVEVQ | 141 | P08574 | |
| VEAEELEEKHREAQV | 691 | O14578 | |
| ETLQVEEDRAKAEAV | 291 | Q9H0I3 | |
| EITDEVKVNLTRDVD | 606 | Q8IYR0 | |
| DLEDQRVVKEEEAIA | 136 | P51159 | |
| AALEEGRQKVAEEIE | 581 | Q9ULJ1 | |
| ESVDAEEVVREIDKL | 1131 | O14917 | |
| AVVQIDTARELEDAD | 66 | Q13702 | |
| SAAEIVREIENIEKT | 296 | Q9NS91 | |
| VDKEDRQVTTEEAQT | 126 | Q9NP90 | |
| QLEEEAKAREAANTV | 451 | O75916 | |
| ADAVVQVEDTELIRE | 421 | Q9NQX3 | |
| ETDAIQRTEELEEAK | 1376 | P12883 | |
| RLQEAEEAVEAVNAK | 1396 | P12883 | |
| QAEDEAQEAVVKVDR | 156 | Q9Y6F1 | |
| EIEAIRQKQEVATAD | 376 | Q8N6L0 | |
| EKEVRAGQVDIEQLD | 31 | Q86YJ7 | |
| EANAEKVTQEIVTER | 896 | Q14126 | |
| QEEVKDLRAVEEAFV | 141 | Q9NRJ5 | |
| VQAEEAAAEITRKLE | 426 | O00567 | |
| SETAEDIIAKEREQN | 421 | Q9NRZ9 | |
| KEAALAAEAEVEVEE | 656 | Q9BR39 | |
| DDDDIVRKIDQSEFE | 566 | P41743 | |
| REEVRKSFVESVEEI | 1506 | Q7RTP6 | |
| KEQREEAAEVASLDV | 481 | Q9BW71 | |
| ALKDVEERVQATIDT | 336 | Q9UBF1 | |
| GETIVEALQREVKEE | 81 | Q6ZVK8 | |
| ENREEEFVKTIVDAL | 551 | P59045 | |
| ETFDQISKVERQVEE | 421 | Q9H8L6 | |
| QEEKESTELRAEEIE | 591 | O75335 | |
| KIDLSEQRQVDAEVA | 121 | Q9NYS0 | |
| EDEINKRTAAENEFV | 291 | P12035 | |
| EEDRFQELKVATAEA | 606 | Q9UPZ3 | |
| VQAKARRVTEDSEEE | 266 | P98095 | |
| KEETVEDEIDVRNDA | 651 | Q14149 | |
| KEVTERAEDEEEINA | 926 | Q9UKX2 | |
| EAEERADIAESQVNK | 1911 | Q9UKX2 | |
| NRFEVEVTKEESEAV | 1151 | Q96JB1 | |
| EDKTISDQESFREVI | 296 | Q9HD67 | |
| SDLDVERDEEAVKTI | 376 | O94806 | |
| VFLKRDDSNESDVVE | 166 | P36776 | |
| AIEVERIKAESAEAA | 486 | P32456 | |
| EDEKAAARVDQEINR | 16 | P30679 | |
| FEEDKVNSTLVVDRE | 231 | Q3BBV0 | |
| ETRVAQKELEEAVTS | 3716 | Q9UPN3 | |
| TTDADKIEDEVTRQV | 7116 | Q9UPN3 | |
| EFAAKIIEEEERVDI | 106 | Q8NBN7 | |
| ESEAEVQAALDKARE | 566 | P21439 | |
| RKRSVAVSDEEEVEE | 736 | Q9Y6X9 | |
| DEEKTLREQEIVASS | 156 | P49643 | |
| AFIVTDEDIRKQEER | 361 | Q9UBB5 | |
| ALREAATAVEQEKEI | 41 | O95816 | |
| EFERVVVELENVKSE | 1001 | Q66GS9 | |
| EVKEELESISEDVQA | 96 | Q9Y2V7 | |
| DARNISKEIRESVEE | 3051 | Q8NCM8 | |
| EEDLRKVDNEFETVA | 746 | Q6AI39 | |
| EETVVNKRDEEQHLE | 461 | P51587 | |
| ALRESVEEATKNVEV | 791 | Q0VF96 | |
| RKVEAVQNLVEAAEE | 136 | Q7Z3S7 | |
| EEAERLTTEEQEKVA | 351 | P48165 | |
| SARKAVDEEEEAVEE | 841 | O75417 | |
| ENFEEVARSKDIEVL | 1346 | Q12955 | |
| VVANNETEEIKDERA | 21 | Q14314 | |
| AAAEEQIKVLEVTEE | 41 | Q96P70 | |
| EAAEVTRKVEETDIV | 3776 | Q14204 | |
| EEEEEVQLKSARRAT | 3796 | Q03164 | |
| NTSLDERERKVEAEV | 616 | Q9NT22 | |
| DTRIDADAIVEKIVQ | 321 | Q5T9C2 | |
| VDDTRVDADDIVEKI | 296 | Q5T8I3 | |
| QEKERAIEATNAEIT | 506 | Q5M9N0 | |
| ASAIAEEEQLTREIE | 441 | Q9BY12 | |
| ETEDVSNRNVVKEVE | 66 | Q9HBV2 | |
| AENEKDRADQTVLTE | 636 | P05060 | |
| KAVLEQEETAAASRE | 911 | Q9Y2J2 | |
| EEQAKRLEEEEAAAE | 51 | Q5T280 | |
| RKEEQEVQATLESEE | 151 | Q08211 | |
| SDVEELVEKENQASR | 351 | Q16363 | |
| KRLAETQEEISAEVA | 106 | Q9Y383 | |
| TQEEISAEVAAKAER | 111 | Q9Y383 | |
| IRVDVADQAQDKDRD | 166 | P23588 | |
| EVEEQEKQLTTDAAR | 116 | Q96G25 | |
| EKTEDDVEREAQLVE | 1121 | Q9H1H9 | |
| LEETDRRTAKDVVEN | 196 | P47897 | |
| EQIRSLEEEKAAVTE | 101 | Q9NP81 | |
| AEVKVEQEREIESEA | 81 | Q96DX7 | |
| DVAIEEKQEVSRVLE | 681 | Q96R06 | |
| RELIAEAKAEVTEEV | 301 | Q9H2G2 | |
| AFVEELDKVESQERE | 1191 | Q02880 | |
| FEEDKVNSSLVVDRE | 196 | Q3BBV2 | |
| FEEDKVNSSLVVDRE | 231 | Q86T75 | |
| KRRNVATAEEETEEE | 46 | P52294 | |
| EVAEIRQEDEAEKAA | 246 | P22732 | |
| DDITVVDVEKQIEAF | 811 | Q8NDZ2 | |
| ARVRELESEVESEQK | 1821 | Q9Y623 | |
| KEVTERAEDEEEINA | 921 | P11055 | |
| EAEERADIAESQVNK | 1906 | P11055 | |
| DDTVQRFAINKEEEI | 231 | Q14191 | |
| EKARKAEEATEAQEV | 166 | O75683 | |
| LVKTEEETAQAVAAE | 216 | Q96JS3 | |
| EEDIRAATQAKAEQV | 2251 | Q6ZRS2 | |
| NEKEEESVRETSLEV | 421 | Q7Z745 | |
| ETELEDDIARVEAIS | 1126 | Q7Z745 | |
| EEELEAERTARAKVE | 1121 | P13533 | |
| EAAIVQAESEETKER | 321 | Q9UHB9 | |
| EQTEEELERAASTIK | 451 | O15269 | |
| EVQAEKADDTERLVE | 806 | O94911 | |
| LVEREDFVEAVKEEA | 411 | Q969K4 | |
| VKEEAAAVAARQETD | 421 | Q969K4 | |
| KTVRSFANEEEEAEV | 376 | Q9NP78 | |
| ERARIEAEEKAAAQE | 291 | Q05682 | |
| EAAIKTADDEAVLQV | 381 | Q6J9G0 | |
| EIVDERAVQDVESLS | 181 | Q9UBS8 | |
| AAEFQTKTEEEEIDR | 691 | Q13435 | |
| VEEVSADVVEIAKEL | 421 | Q96MW7 | |
| EKEIAETRFEVAQVE | 1206 | P12270 | |
| AVEKAAELTATQVEE | 816 | O75717 | |
| EAVTADSEVLEERQK | 26 | Q9NPL8 | |
| EAERKIIEENITSAA | 296 | P78362 | |
| VEVNASRQEAKLTEE | 251 | O15344 | |
| DTIFDNEAKDVEREV | 121 | Q9UKF7 | |
| SEIRFEIEDVNNKTE | 1361 | Q9UQD0 | |
| DVKSLAEADEQEVVA | 106 | Q9NRW7 | |
| EVELASRVKAEAEAA | 1651 | Q15149 | |
| EDLVKEAVSQVRAEA | 976 | Q96JH7 | |
| RLEVAEAEEEETSIK | 131 | O15213 | |
| EEEISKVAAERRASE | 121 | Q8IYW5 | |
| RVADVVARAEAEEKT | 246 | Q9NXH8 | |
| EVSKIQEAAVQSDRD | 926 | Q86T82 | |
| QIVRAETELSAEEKA | 21 | Q9UL62 | |
| SAEQDKRAVERLEVE | 216 | Q00341 | |
| SFVDQVREIIEKADE | 1176 | Q9H4A3 | |
| EERAKIIFAIDQDVE | 61 | Q9NR00 | |
| LQVEISDAVSERDKV | 26 | Q86XE0 | |
| LKDEERAEEIVAAQE | 1221 | Q9Y4A5 | |
| VTEEEANRLAEELVA | 151 | Q49AM3 | |
| DREVSEISIVDIANK | 521 | Q14789 | |
| EEEINKRTAAENEFV | 221 | Q3SY84 | |
| EKVDRAVEAAERAAT | 361 | Q8WXH2 | |
| ASRIESLEQEKVDEE | 331 | O14974 | |
| RVAEEAIEEAISKAE | 196 | Q8NFW9 |